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ABSTRACT 
Electrospun antibody-functionalized poly(dimethyl siloxane)-based 
meshes for improved T cell expansion 
Alexander P Dang 
 
Adoptive cell transfer (ACT) has garnered significant interest in recent years within the medical 
field due to its potential in providing an effective form of personalized medicine for patients 
suffering from a wide range of chronic illnesses, including but not limited to cancer. By leveraging 
the patient’s own cells as the therapeutic agent, concerns over patient compatibility and adverse 
reactions are significantly reduced. Central to this therapy is the ability to optimize cell quantity 
and cell activation in order to produce a more robust infusion to the patient.  
This thesis focuses on two main aspects. The first is the materials synthesis and development of a 
novel platform for the ex vivo expansion of human T cells for ACT, while the second aims to 
elucidate the underlying structural mechanics of this platform. This platform, which consists of an 
electrospun mesh of micron and sub-micron diameter poly (dimethyl siloxane)-based fibers, aims 
to maintain the high surface-area to volume ratio characteristic of the current clinical gold 
standard. This also simultaneously allows for effective leveraging of T cell mechanosensing, a 
phenomenon previously discovered by our lab that is the ability of a human T cell to respond 
differently to surface mechanical cues. By modulating the concentration of poly (ε-caprolactone) 
in these fibers, a biocompatible polymer, the mesh mechanical rigidity was varied: this effectively 
allowed for the leverage of T cell mechanosensing by maintaining a low and tunable Young’s 
modulus throughout. Additionally, safety concerns involving transfusion of the expansion platform 
into the patient were addressed by having a single continuous substrate instead of an array of 
disjoint ferromagnetic beads. 
Our results thus far indicate that this soft mesh platform can produce upwards of 5.6-12.5 times 
more T cells in healthy patients than the clinical gold standard while maintaining comparable levels 
of cellular activation and phenotypic distributions as measured through IFNγ secretion and 
expression of surface proteins CD107b, CD45RO, and CCR7, respectively. Additionally, this 
platform demonstrates the ability to produce improved expansion of exhausted (PD-1high) T cells 
from CLL patients compared to the clinical gold standard across all analyzed Rai stages. Finally, 
experiments have shown our platform to be scalable to produce clinically relevant levels of cells (> 
50 million) from a given starting population, thus indicating its potential in adaptation in larger 
scale in vitro systems. The currently demonstrated capabilities of our mesh platform thus hold 
significant promise in the clinical development and adoption of ACT, as well as the development 
of larger scale in vitro systems. 
In order to elucidate the underlying structural mechanics of our platform, quantitative AFM 
studies have indicated a force-dependency in rigidity measurement, thus indicating that standard 
Hertzian contact models and their derivatives (DMT, Sneddon, etc.), may not be ideal in calculating 
the rigidity of this material. In order to better model the effective Young’s modulus (    ) of the 
mesh and account for cantilever beam-bending type mechanical deformation, a modification of 
Euler-Bernoulli theory was established. This mathematical model was subsequently used to 
correlate fiber geometry parameters to bending stiffness, thus allowing for us to estimate      for 
a range of meshes. Subsequent T cell expansions and comparison of data to previous expansions 
on planar surfaces provided verification of our model.
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Introduction and Motivation 
 
According to recent reports by the National Cancer Institute, cancer remains one of the leading 
causes of death in the United States, with approximately 16.5 million Americans currently 
diagnosed with some form of cancer, and an additional 1.5-2 million new cases projected for 2017 
alone1. As such, cancer is currently projected to become the leading cause of death in the United 
States by 2024 and thus poses a significant burden to the current healthcare system. In spite of its 
extensive history of clinical use and relatively low cost, chemotherapy has significant drawbacks 
for both the patient and the physician due to its numerous side effects such as 
immunosuppression, chronic nausea, and damage to friendly tissue2. Bone marrow 
transplantations, while effective, likewise induce immunosuppression and furthermore present 
the physician with concerns involving donor-patient compatibility, donor availability, and tissue 
harvesting. Additionally, bone marrow transplantations invoke significant financial costs to both 
clinics and patients alike1. In recent years, more targeted therapies such as monoclonal antibody-
based drugs have seen increased use in the clinic due to their ability to induce little to no significant 
damage to friendly tissue, while maintaining a high level of tumor cell targeting efficiency. 
However, high costs to both the clinic and the patient, as well as immunosuppression remain 
burdens to the physician and the patient2. Furthermore, patient compliance arises as a concern 
due to the requirement of multiple doses for full treatment2. Therefore, there currently exists an 
unmet clinical need for an effective form of cancer therapy that can simultaneously minimalize 
collateral damage to non-cancerous tissue and other side effects while being cost-effective.  
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To address these concerns, researchers have turned towards cell-based adoptive immunotherapy 
in recent years, a growing field that has shown recent successes towards the treatment of various 
chronic diseases, especially cancer3. Cellular therapy is rapidly developing as a powerful 
component of medicine, complementing the use of small-molecule and biologic agents. Adoptive 
cell transfer (ACT) of T lymphocytes for treatment of cancer is a prominent example of this 
emerging approach. Current implementations of ACT involve ex vivo expansion of a starting 
population of cells, producing clinically relevant numbers of these agents and also allowing 
manipulations that are not practical in vivo, most notably introduction of chimeric antigen 
receptors (CARs)4. In this therapy, a specific subset of the patient’s own immune cells is removed 
from the body and cultured, or expanded, in an ex vivo environment whilst being stimulated 
against the target antigen. Further modification of cells, such as the introduction of a new T cell 
receptor (TCR) via a viral transduction, is also possible during this process. Upon reaching a target 
number of expanded cells, stimulated cells are isolated from the culture and ultimately re-
introduced into the patient3. By leveraging the patient’s own cells in order to fight the disease via 
targeting of a specific antigen, one effectively attains a high targeting level of cancerous cells, low 
adverse host-response, and can furthermore induce long-term immunity to the patient, thus 
significantly reducing the probability of remission5. Furthermore, currently existing technology can 
be readily adapted to support such therapies on a large scale, such as by the use of industrial-scale 
bioreactors and cell culture facilities. Full deployment of this type of ACT will require overcoming 
several challenges in cell manufacture, including technology scalability and minimization of the 
level of technical skill needed to carry out cellular expansions.  
 
3 
Although first described in detail by Rosenberg et al through their use of ex vivo expanded natural 
killer (NK) cells to treat metastatic melanoma in human subjects6, current immuno-therapeutic 
treatments involve the use of other types of immune cells, such as T cells and dendritic cells (DCs). 
One particular application of interest currently is the use of T cells for treatment of both acute 
lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL)3, 7. Other treatments include 
the use of DCs for prostate cancer therapy7. Given the wide range of current and potential 
applications of this field, adoptive immunotherapy presents researchers with promising solutions 
for oncological treatments and other chronic illness. 
In current implementations, T lymphocytes are expanded in an ex vivo environment followed by 
transfusion into the patient, thus allowing for engineering of T cells with high target specificity and 
low levels of host response3,5. The usage of T cells as opposed to other types of cells (such as NK 
cells) is of particular advantage due to the ability for a subset to differentiate into effector memory 
and central memory T cells, thus promoting long-term immunity. Although there are a variety of 
platforms for T cell expansion including the ImmunoCultTM tetrameric antibody complexes by 
Stemcell Technologies and the nanobead-based T Cell Activation Kit by Miltenyi Biotec, in what is 
commonly accepted as the clinical gold standard, the ex vivo expansion of T cells is typically 
initiated by exposing isolated patient T cells to rigid polystyrene beads (Dynabeads®) of 
approximately 4 µm in diameter that present covalently attached activating antibodies, or agonists, 
to surface proteins CD3 and CD28, which together provide the primary and secondary activation 
signals for T cells respectively3. Cells are cultured on the Dynabead® platform for up to four days, 
after which beads are separated from expanded T cells in order to prevent overstimulation. This 
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is facilitated via the embedding of the beads with ferromagnetic cores, thus allowing for magnetic 
removal of beads prior to reintroduction of expanded cells into the patient9.  
However, Dynabead®-based treatment can be improved upon in three ways. First, it has been 
shown that post-bead separation, residual beads still remain in solution and stand a high risk of 
being introduced into the patient10. This unaddressed concern may potentially present future 
health complications to the patient. An additional improvement would be the increase of agonist-
coated surface area-to-volume ratio, which can be made possible from the transition from a 
magnetic bead-based format to a three-dimensional fibrous mesh-based format. The use of 3D 
fibrous meshes is of particular advantage due to their pre-existing usage in tissue scaffolds, 
stemming from their ability to mimic the natural in vivo environment11, or in the case of T cells, 
the cortical thymus12,13. Finally, recent experiments have indicated that T cells undergo 
mechanosensing via non-integrin-based and non-cadherin-based cell-substrate interactions14. 
Although the exact mechanism for this phenomenon has not yet been fully elucidated, it has been 
indicated that higher levels of cell proliferation of human T cells can be induced by culturing on a 
less rigid substrate, particularly surfaces with rigidities on the range of 100 kPa to 2-3 MPa. As the 
Dynabead® platform currently exhibits Young’s moduli on the order of single digit GPa, a new 
softer platform may effectively improve current cell expansion capabilities through the leveraging 
of T cell mechanosensing. To summarize, it is hypothesized that by combining these three factors, 
one can fabricate a more robust and safer platform for T cell-based adoptive immunotherapy via 




Electrospinning offers a facile and cost-efficient method for the synthesis of aligned and unaligned 
polymeric fibers with uniform diameter ranging from several microns down to tens of 
nanometers15, 16. In this process, a solid polymer is dispersed in an organic solvent and is pumped 
at a fixed rate through a small orifice while being subjected to a very high electric potential towards 
a grounded collection electrode. As the liquid approaches the tip of the orifice, the liquid stream 
experiences three conflicting forces: electrostatic repulsion between particles due to the charging 
of the liquid pushing the jet apart, surface tension at the liquid-air interface holding the liquid jet 
together, and the aforementioned electric field, which drives the liquid jet towards the collection 
electrode. These forces ultimately stretch and pull the liquid jet towards the collection electrode 
at high speeds, thus causing the solvent to vaporize and forming a solid polymer fiber. Due to its 
scalability and ease of operation, electrospinning offers researchers unique advantages towards 
the synthesis of 3D fibrous meshes15.  
One successful platform for initiating expansion is the Dynabead® (ThermoFisher Scientific) system, 
which consists of microscale plastic beads that present on their surface activating antibodies to 
CD3 and CD28, two surface proteins on the T lymphocyte outer membrane that together promote 
functional activation and subsequent cell proliferation. The use of microbeads makes this 
approach highly scalable, making this platform appropriate from bench to clinical setting, and is 
readily compatible with current bioreactor technologies9. 
This thesis effectively introduces an improved platform for T cell expansion that brings together 
two concepts of biomaterials design. The first is the use of a fiber mesh as the activating substrate, 
which similarly to microbeads provides a large surface area to volume ratio for T cell activation. 
Importantly, this format offers simpler removal from the cell growth environment than the 
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Dynabeads platform; in that system, a magnetic field is used to collect the beads, but removal is 
often incomplete, and thus can pose potential, unstudied complications if subsequently 
introduced into the patient. The second concept captured in this new platform is the use of 
mechanical rigidity to enhance cell growth. The ability of cells to sense and respond to the 
mechanical properties of the extracellular environment has been largely established, 
predominantly in the context of cells interacting with extracellular matrix proteins through integrin 
receptors17. In subsequent studies by O’Connor et al., it was demonstrated that T cell expansion 
also exhibits sensitivity to the mechanical rigidity of the activating material. In that study, anti-CD3 
and anti-CD28 antibodies were attached to planar substrates of the Sylgard 184 formulation of 
poly (dimethyl siloxane) (PDMS)18. Reducing the ratio of cross-linker to elastomer base produced 
a change in bulk Young’s modulus, decreasing it from the typical 2 MPa to the range of a few 
hundreds of kPa, but more importantly, increased the number of T cells produced in a single round 
of expansion by several fold. This was unexpected in that CD3, the T cell receptor (TCR) complex 
of which it is part, as well as CD28 have much weaker connections to the contractile cytoskeleton 
than do integrins and other transmembrane receptors normally associated with cellular 
mechanotransduction. This primary purpose of this report thus seeks to create a mechanically soft, 
mesh fiber platform for the purpose of improving expansion of T cells. 
This platform was fabricated using electrospinning: a well-established, high-throughput technique 
in which a polymer in solvent is dispensed from a needle under a high electric potential towards a 
target. This balance of electrostatic forces and surface tension promotes formation of a well-
controllable fiber geometry, which is captured in the final material15. This approach is well suited 
for producing fibers of micrometer to sub-micrometer diameters, and is well-suited for polymeric 
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solutions in which evaporation of a working solvent leads to solidification of the final material16. 
Although processing considerations such as the toxicity and commercial availability of the solvent 
should be taken into consideration for the commercial development of a clinically used platform, 
such factors will not be explored in this thesis. 
PDMS is a biocompatible elastomer formed by the crosslinking of multiple siloxane-based 
backbones via shorter carbon-based linker units. As such, PDMS offers a facile method for the 
variation of surface rigidity through modulation of the crosslinker-to-base ratio. This variation 
allows for production of PDMS slabs with Young’s moduli ranging from tens of kPa to hundreds of 
MPa. Furthermore, its current use in a wide range of applications, including various FDA-approved 
medical devices, as well as its commercial availability and low cost, make it an attractive material 
for the fabrication of substrates for cell stimulation19.  
Due its viscosity and immiscibility in most organic solvents however, electrospinning of pure PDMS 
fibers remains a challenge, regardless of grade and composition20,21. Notably, formation of a PDMS 
elastomer typically involves the catalyzed formation of crosslinks between long chains in a curing 
phase, rather than removal of a solvent. Therefore, the formation of well-defined PDMS nano or 
microfibers via electrospinning has to date been only reported in experiments where the PDMS 
pre-polymer is mixed with another polymer such as poly (vinyl pyrrolidone) (PVP) or poly (methyl 
methacrylate) (PMMA) in an organic solvent. Electrospinning of pure PDMS microfibers remains 
non-elucidated as of this writing21. 
An approach used in current experiments is to combine PDMS with poly(ε-caprolactone) (PCL), a 
biocompatible polymer that has been used extensively in electrospinning and other medical 
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devices22, in the feed solution in order to allow for a more suitable viscosity and processing of the 
elastomer material. Because the bulk rigidity of PCL can vary anywhere from tens of MPa to single 
digit GPa22, the addition of PCL to a PDMS material will inevitably make the overall Young’s 
modulus higher than that of pure PDMS. Although a material with a low Young’s modulus is desired 
for the current application, the addition of a more rigid viscosity-modulatory material may be 
essential for the formation of the material as a whole. 
As T cell focal adhesions are on the scale of hundreds of nanometers23, central to the notion of 
rigidity-based mechanosensing is what is the rigidity of the material on a very local scale: cell-
material interactions will undoubtedly have a profound effect on the cell proliferation and 
activation. While standard uniaxial tensile testers readily provide facile measurements of bulk 
rigidities, these figures would not accurately reflect rigidities on a cellular level, again, due to the 
small length scales and geometries involved. Therefore, in order to probe substrate rigidities on 
the nanometer to micrometer scale, atomic force microscopy (AFM) presents itself as an ideal tool, 
in particular, its ability to probe nanometer-level mechanical properties of materials22. By 
detecting minute shifts in the deflection of the incident laser along with changes in voltage in the 
piezoelectric elements of the cantilever arm, a modern AFM can measure properties such as 
Young’s modulus, tip adhesion, and tip deflection down to single digit Pa, pN, and nm, 
respectively22. 
Typical AFM measurements and rigidity calculations rely on underlying assumptions on the 
material itself. One of the most basic and time-trusted models for AFM contact measurements is 
the Hertzian contact model. In this model, the AFM tip is modeled as a hard, minute tip exerting a 
point force that does not experience any type of strain whatsoever as it comes in contact with the 
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material24. The Hertzian model further assumes that the substrate is a semi-infinite plane, the 
deformation of the material is purely elastic, and that local warping around the point of contact of 
the material does not occur, i.e., work hardening is negligible. In this model, the force applied by 









In this equation,    represents the AFM tip radius,    is the depth of the indentation,    and   
represent the Young’s modulus and Poisson’s ratio of the sample, respectively, and   represents 
the force exerted by the tip downwards onto the sample. Terms on the left thus correspond to 
properties of the indentation while indenter while terms on the right correspond to sample 
mechanical properties. While this model inevitably has its flaws (local deformation of a material 
will always occur, tips will exhibit at least some van Der Waals forces-based adhesion to the 
material, etc.), it nonetheless provides a reasonable figure for the rigidity of bulk materials. 
Various models have sought to improve on the Hertzian contact model and are thus more 
prominently used in modern AFMs. One such model proposed by Derjaguin, Muller, and Toporov, 
colloquially known as the DMT model, assumes a basic Hertzian interaction between the tip and 
substrate, but factors in forces of attraction outside the circular tip contact area25. Another 
common model by Sneddon has also seen common use in AFM, in which the indenting tip is 










In this model, the applied AFM force    is seen to scale proportionally with the square of the 
indentation depth, although the contribution from the sample itself remains constant. It should 
be noted however that one key fundamental assumption for both the DMT and Sneddon models 
is that the material is a semi-infinite plane24,25. It should be noted that AFM manufacturers typically 
apply their own proprietary modifications of these models in the calculation of surface rigidity in 
order to account for a wide range of factors, such as static electricity, magnetic moments, minute 
changes in tip resonant frequency, etc25. 
If one was to use a standard sharp conical AFM tip with diameters under 50 nm, neither of these 
three contact models would likely be the most accurate for measuring the rigidities of fibrous 
meshes with diameters on the order of single microns. One reason for this is readily apparent: 
mesh fibers cannot be accurately approximated as semi-infinite planes. If one was to imagine a 
single mesh fiber as a simply supported cylindrical beam subjected to a single point force (no 
adhesive forces between the beam and the support), one could imagine a rudimentary model for 
the interaction between a sharp conical AFM tip and mesh fiber as described below (see fig. 1). 
 
Figure 1: Standard beam bending model for a single mesh fiber with effective length  , radius  , 
and bulk modulus   supported by two simple (horn) supports 
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According to unidimensional cantilever mechanics, the maximum deflection of the beam   in this 
case can be readily calculated as the following, where   represents the second moment of inertia 








A back-of-the-envelope calculation with mesh parameters, herein approximated as 10-6 m, 106 Pa, 
10-9 N, and 10-5 m for  ,  ,  , and  , respectively, reveals that   would be on the order of tens to 
several hundreds of nanometers. As mesh fibers would ideally have dimeters in the range of single 
digit microns, a deflection of up to several hundred microns would undoubtedly have non-
negligible skew on rigidity measurements. Furthermore, tip adhesion and local deformation of the 
material become non-negligible factors as unlike metals and ceramics, PDMS is an inherently 
viscous and soft material. 
Therefore, the goal of this thesis is to identify parameters of the final mesh material that can 
optimally promote T cell activation and expansion, as well as to delve into the mechanics of how 
fiber geometry can affect human T cell mechanosensing. Specifically, this thesis project will strive 
towards the construction of a mathematical model for the perceived rigidity of a fiber as a function 






T cell activation and phenotype 
The activation of CD3+ T cells in the body is a key aspect of the adaptive immune system, assisting 
the body in developing a targeted response to a specific set of antigenic markers. Activated 
conventional T cells can be generally divided into CD4+ and CD8+ subtypes (often termed helper T 
cells and cytotoxic T lymphocytes, respectively)13. The former is generally involved in enhancing 
antibody production from B cells and secreting vital cytokines to further activate the adaptive 
immune system, whereas the latter typically seeks out and terminates infected host cells, tumor 
cells, and bodies expressing non-host antigens through association with their major 
histocompatibility complex I molecules (MHC-I)13. These cells are therefore most commonly 
associated with implant and transfusion rejection, although there have been studies showing that 
certain helper T cells occasionally express CD8 and likewise, certain cytotoxic T lymphocytes 
occasionally express CD4. In addition to these two main types, regulatory T cells (Tregs) suppress 
the function of both CD4+ and CD8+ T cells. Naïve T cells, which are formed in the medullary and 
cortical thymus, get activated through two independent signaling steps in the body to ensure that 
premature activation or over-activation does not occur. The first signal occurs through the 
antigen-specific T cell receptor (TCR), and causes signal propagation through surface protein CD3, 
in particular, the ε-subunit. This primary stimulatory signal occurs in the body through an antigen 
presenting cell (APC), most commonly a macrophage or dendritic cell through binding with the 
major histocompatibility complex II (MHC-II) that has already been loaded with target antigen. 
Following the primary stimulatory signal, secondary stimulation signal comes via surface protein 
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CD28. This activation signal comes from binding with CD19 on a so-called licensed B cell expressing 
CD80 or CD86. Both signals are required for T cells to transition from naïve T cells to activated T 
cells: those that only receive TCR signaling but not any other co-stimulatory signal leads to the 
formation of anergic T cells, while naïve T cells that bind to friendly host antigen undergo apoptosis 
to prevent autoimmune attacks13. 
Although multiple classification schemes exist for activated T cells, these cells are generally divided 
into three separate subcategories. Effector T cells broadly encompass most of the cytotoxic T 
lymphocytes as well as helper T cells and Tregs that are formed during the adaptive immune 
response. These cells, most of which will undergo apoptosis after the target or invading body has 
been removed, typically express CD44 and CD45RA, but not CD62L or CCR7 (also known as CD197). 
Effector memory T cells on the other hand are long-lived T cells that will circulate in the peripheral 
blood after the immune response has died down, and are designed to amplify the initial immune 
response should the same antigen or set of antigens present themselves in the body again. These 
cells typically express CD45RO (a truncated form of CD45RA and a typical marker for memory cells), 
but do not express CCR7 or CD62L since they do not have the need to further migrate to the 
periphery. Finally, central memory T cells are functionally similar to effector memory cells, but 
primarily reside in the lymph nodes and central blood, although they may migrate out into the 
periphery. These cells express both CCR7 and CD62L, as well as CD45RO. Due to the different 
surface marker expression of these cell types, performing flow cytometry with stains for CCR7 and 
CD45RO can gate a mixed T cell population into effector, effector memory, central memory, and 
naïve T cell sub-populations13. 
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The current model for ex vivo cell expansions typically involves sending patient cells from the clinic 
to an external facility for processing. Following activation and proliferation, the final cell product 
needs to be transported back to the clinic for infusion into the patient27. Although this isolation, 
growing, and transfusion process may need occur more than once for any given patient, one 
constant factor is the relatively high cost for purchasing and maintaining the bioreactor systems 
required for this expansion process, in addition to paying technicians and bioreactor operators. 
Although the need for a technology to optimize cell number is readily apparent, the demands of 
the patient naturally gives rise to the question of what phenotypic distribution is optimal. When 
the final cell product is transfused back into the patient, these cells will have seen target antigen 
for the second time. That is, cells will be undergoing secondary stimulation, or restimulation, 
instead of the primary stimulation in the bioreactor environment. Therefore, for the purposes of 
adoptive immunotherapy, a higher percentage of both effector memory and central memory cells 
would be optimal for the patient, as these cells can readily stimulate a response to target antigen, 
self-replicate, and / or differentiate into effector cells. It is postulated that an infusion with a higher 
percentage of effector cells but a lower percentage of effector memory and central memory cells 
will not trigger as strong of a response due to the short-lived nature of effector cells without the 
presence of target antigen27. 
T cell mechanosensing 
It has been previously determined that many types of cells in the human body ranging from 
chondrocytes28 to neurons28 sense and respond to mechanical forces via focal adhesions, typically 
through integrin-based and cadherin-based interactions26. Such interactions with the extracellular 
environment via mechanosensing are critical in order for individual cells to move locally, regulate 
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self-repair, and undergo differentiation28. Under normal physiological conditions, the activation of 
naïve T cells occurs in the thymus through the recognition of a target antigen presented via DCs. 
In the first part of activation, naïve T cells are engaged via the T cell receptor (TCR) through 
interaction with a target antigen-coupled type II major histocompatibility complex (MHC-II) and 
the subsequent formation of the immune synapse. This initial stimulation subsequently allows for 
co-stimulation via CD28 on the surface of the T cell thorough coupling with CD19 on the surface 
of a B cell15, 16, 18 and the prevention of apoptosis for the naïve T cell. Therefore, it should be noted 
that both stimulation via the TCR and co-stimulation via CD28 are necessary for T cell activation. 
Although it has been previously established that T cells do not undergo mechanosensing via 
integrin-based receptors, the exact signaling mechanism by which T cells translate mechanical 
cues into cellular events is currently not fully understood.  
Initial experiments in this field performed by Judokusumo et al12 to demonstrate that T cells in fact 
undergo mechanosensing focused on expression levels of interleukin-2 (IL-2), a cytokine involved 
in immune responses16, in addition to expression levels and patterns of zeta-chain associated 
protein kinase 70 kDa (ZAP-70) and Src family kinase proteins (SFK) around the immune synaptic 
region as a function of substrate rigidity. The evaluation of ZAP-70 and SFK was of particular 
importance due to their previously known role in signal transmission and transduction in T cells. 
For this experiment, isolated mouse CD4+ cells were cultured on poly(acrylamide) gels of rigidities 
at either 10, 25, 100 or 200 kPa coated with anti-CD3 and anti-CD28 antibodies. Results indicated 
that for substrates with Young’s moduli below 25 kPa, IL-2 secretion levels decreased with 
decreasing rigidities, while there was a positive but saturating correlation between IL-2 levels and 
substrate rigidity. Furthermore, their results indicated that while stiffer substrates all exhibited 
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increased cell adhesion, there again was a saturating effect. Analysis of the presence of ZAP-70 
and SFK via confocal microscopy revealed a similar pattern in which cells cultured on substrates 
with Young’s moduli equal to or above 25 kPa exhibited higher levels of ZAP-70 and SFK than the 
softer 10 kPa substrate, thus fostering the notion that for substrates with rigidities below a certain 
threshold, T cell mechanosensing fundamentally behaves differently.  
While the experiment performed by Judokusumo et al. provided a suitable framework for future 
T cell mechanosensing studies, this experiment did not offer significant insight into the behavior 
of non-murine T cells. In order to address this knowledge gap, this experiment was subsequently 
expanded upon by O’Connor et al.18 through their usage of human CD4+ and CD8+ cells in order to 
further establish an optimal range of substrate rigidities for T cell stimulation. In this experiment, 
planar slabs of poly (dimethyl siloxane) (PDMS) of Young’s moduli ranging from 50-100 kPa to 
approximately 2.3 MPa were fabricated by modulating the ratio of PDMS base to crosslinker ratio. 
Substrates were then functionalized with anti-CD3 (OKT3) and anti-CD28 (clone 9.3) antibodies 
and ultimately used to culture isolated CD4+ / CD8+ human T cells. In order to measure T cell 
activation, researchers focused on cell counts (population doublings) over the course of up to 14 
days and IL-2 expression levels over the course of 72 hours. Results for cells cultured on PDMS 
surfaces were subsequently compared against human T cells cultured on anti-CD3 and anti-CD28-
coated microbeads of approx. 4.5 µm diameter. 
The data from this study indicated that there was a correlation between lower substrate Young’s 
moduli and higher IL-2 secretion levels as well as population doublings. Specifically, it was 
observed that an approximate four-fold increase in overall culture yield was obtained by 
transitioning from the stiffest PDMS substrate (1:5 ratio of dimethyl siloxane monomer to base) 
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to the softest PDMS substrate (1:50 ratio of crosslinker to base) as seen in figure 2A of their paper. 
Researchers attributed this to more prolonged blast phase induced on cells cultured on the softer 
substrates due to cell volume data, as seen in figure 2C. It should be noted that for this experiment, 
an average cell volume of over 400 fL was considered to be blasting. This notion was further 
supported by carboxyfluorescein succinimidyl ester (CSFE) assays in conjunction with flow 
cytometry to track cell divisions and generations, as seen in figure 2E of their paper. Here, it was 
observed that cells cultured on planar substrates with softer rigidities underwent more divisions 
than cells cultured on stiffer substrates, especially with concentrations of IgG capture antibody 
below 1 µg / mL at 72 hours’ post-stimulation. Likewise, cells cultured on the softest planar 
substrates exhibited approximately 3 times as much IL-2 as cells cultured on the stiffest planar 
substrates as measured by quantitative real-time PCR. However as seen in figure 2D of their paper, 
it was noted that this phenomenon was not the same for microbeads, with all rigidities yielding 
approximately equal levels of interleukin-2 (IL-2). These results therefore indicate that substrate 
mechanical properties, substrate morphology, and antibody presentation are all potentially key 
variables in controlling the activation and proliferation of human T cells.  
Electrospinning and the use of electrospun micro- and nanofibers for cell culture and tissue 
engineering 
The usage and development of electrospun fibers of micron and sub-micron diameters has been 
previously widely reported in the literature, with applications ranging from drug delivery to tissue 
engineering. First developed and patented by James Cooley in 1934, electrospinning has gained 
significant traction in recent years due to its ability to produce biomaterials and biomedical 
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products such as polymeric fibers and mats with controllable physical and chemical properties in 
a high-throughput and cost-efficient manner.  
In electrospinning, a spinning solution consisting of a polymer uniformly dispersed in a volatile 
solvent is pushed slowly towards a grounded collection electrode at high electric potentials, 
typically in the kV range (see figure 2). 
 
Figure 2: Basic electrospinning setup showing one potential polymeric feed formulation 
As the highly charged polymer approaches the tip of discharging device, which is typically a blunted 
and sanded needle, the polymeric solution experiences a combination of two forces: the 
electrostatic repulsion between individual molecules in the spinning feed, driven by the charging 
of the fluid, and the intermolecular forces of attraction between those same molecules and 
surface tension, trying lowering the system free energy. This balance of free energy-reducing 
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attraction and electrostatic repulsion forces give rise to what is known as a Taylor cone or a Taylor 
instability at the tip of the discharging device15. Due to the pull of the electric field towards the 
grounded collection electrode and the unstable nature of the Taylor cone, a whipping instability 
develops, causing the liquid jet to be elongated and spun as it approaches the target. This 
effectively causes the solvent to evaporate and the formation of a solid polymeric fiber on the 
collection electrode. If needed, multiple polymeric streams can be combined into one via co-
electrospinning, provided the polymeric solutions are mutually miscible. Modifications to this 
technology also exist, most notably the usage of a spinning collection drum or mandrill instead of 
a static collection plate, thus giving rise to aligned polymeric fibers15. 
The synthesis of an electrospun nanofibrous poly(D,L-lactide-co-glycolic acid) (PLGA) structure 
with randomly oriented fibers by Li et al in 2002 played a particularly pivotal role in the 
advancement of electrospinning as a viable synthesis tool29. Researchers in this publication cited 
the various properties such as pore size, cell-substrate interaction, and mechanical stiffness of the 
resulting PLGA mesh that would make for an ideal tissue scaffold. Indeed, studies performed by Li 
et al looking at cultures of human mesenchymal stem cells (hMSCs) on these PLGA scaffolds 
showed that cells growth was viable: the hMSCs appeared to adhere to the mesh and penetrate 
into the three-dimensional matrix, allowing for cell growth over seven days. Researchers 
postulated that the mesh’s extracellular matrix (ECM)-mimicking geometry played a role in the 
proliferation of cells: a sentiment that has been echoed across a multitude of publications since 
then. The biodegradable properties of PLGA were also highlighted as a potential benefit due to its 
ability to naturally break down into non-cytotoxic and non-immunogenic components in an 
aqueous environment. Additionally, electrospinning presents several additional advantages over 
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other tissue scaffold synthesis techniques. For example, it does not allow for the presence of 
residual particulates in the matrix as sometimes can occur during particulate leaching, and allows 
for the usage of a very wide range of polymers in the synthesis process, a property that gas 
foaming cannot achieve due to the high levels of heat required. 
Other fibrous mesh properties that have been of particular interest over the years includes fiber 
orientation, which can be defined as the average angle one fiber makes with another, with values 
ranging from zero to 90 degrees. A mesh with perfectly aligned fibers would thus have an average 
incident angle of zero degrees, while a perfectly, randomly unaligned mesh would have an average 
incident angle of 45 degrees. It should be noted that given a uniform fiber distribution, an 
unaligned mesh would may or may not have a higher pore size than an aligned mesh, due to the 
fact that inter-fiber spacing, which is primarily driven by solvent-polymer interactions during the 
spinning process, is not dependent on fiber alignment15,16. Previous publications have successfully 
demonstrated the effect that fiber orientation has cell proliferation, although the exact difference 
between aligned and unaligned fibers varies by cell type30.  
One particularly notable study in this direction was conducted by Liu et al in 2015, in which 
researchers looked at the effect of fiber orientation on the proliferation of rabbit annulus fibrosus-
derived stem cells (AFSCs)30. In this study, freshly harvested AFSCs were seeded onto aligned and 
unaligned electrospun poly(ester carbonate urethane) -urea (PECUU) scaffolds, a more 
biodegradable formation of poly(urethane). In this study, researchers found that AFSCs seeded on 
aligned fibers tended to align themselves with the fibers and exhibited slightly elongated nuclei 
compared to their unaligned fiber counterparts, although cell proliferation did not differ 
significantly. The main difference occurred in molecular expression, particularly through the 
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production of type I collagen molecules: researchers found that in aligned fiber cultures, AFSCs 
produced almost twice the level of type I collagen compared to AFSCs grown on unaligned fibers, 
although type II collagen and aggrecan (a proteoglycan typically produced by AFSCs) expression 
levels were constant across both cultures. This study thus echoed the findings from various other 
studies that the geometry of an electrospun mesh may play a role in certain aspects of cell 
behavior, but not all. This phenomenon also has been seen to vary across different cell types, as 
reported in the literature. 
AFM measurements of single fibers 
The use of atomic force microscopy to determine the rigidity and topography of planar surfaces 
ranging from soft plastics to metals and ceramics has been a thoroughly studied topic31. Assuming 
that an AFM tip can be modeled as a single point force with magnitudes spanning 10-11 to 10-8 N, 
micron-diameter fibers will undergo beam deformation upon probing. Therefore, traditional AFM 
techniques are not ideal for studying rigidities on these types of substrates. 
In order to more fully study the mechanical properties of single polymeric fibers, Baker et al 
utilized a novel fiber anchoring technique, which, coupled with an AFM tip, allowed researchers 
to more accurately calculate the Young’s modulus, yield stress, relaxation time, and other 
properties31. In this study, which focused solely on PCL nanofibers fibers, researchers used a 
combination of lithography and electrospinning to form an array of single fibers that spanned 
rectangular troughs of controlled depth and width. By anchoring the ends of the fiber to the trough 
ridges as seen in figures 3A and B of their paper via a micropipette and UV-activated glue, 
researchers were able to use an AFM tip to apply a set tangential force to the PCL nanofiber. Then, 
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by measuring the deflection of the fiber in conjunction with the laterally applied force, researchers 
were able to construct an effective stress-strain curve. It should be noted that the glue was not 
observed to wick along the fiber and potentially skew rigidity measurements. 
The mathematics used by Baker et al derive from fundamentals of solid mechanics. In reference 
to figure 3B of their paper, the force exerted on the PCL fiber can be determined via simple 
trigonometry. Using the displacement of the fiber and its original length, we can calculate the 
following, where        and          are the forces experienced by the fiber and applied laterally 
by the AFM tip, respectively. That is,         were directed along the axis of the fiber whereas 
         were perpendicular to the fiber’s original conformation. 
  = tan    
 
        




It should be noted that for this calculation,         were one half of the un-stretched fiber length. 
Knowing       , we can proceed to calculate stress as usual with   =        (  
 )⁄ . While   can 
be readily determined from microscopy data (i.e., SEM) assuming a cylindrical fiber, we need a 
way to calculate         . 
There have been multiple equations suggested in the past to calculate          . The most 
fundamental approximation provided by Asay, Hsiao, and Kim34 in 2006 of          =
      cos   sin    where    represents one half of the complimentary angle to the angle of the 
applied force has merits in its simplicity, but has been shown to have inaccuracies as it does not 
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In here,   is the strength of the left-right photodiode signal, which is measured in Amperes.      on 
the other hand, is the lateral force constant of the AFM tip, and is expressed in units of Newtons 
per Ampere: 




In this equation,   represents the Young’s modulus of silicon (taken as 1.690 x 1011 N/m2),  ,  , 
and   are the width, length, and thickness of the cantilever, respectively, and ℎ represents the 
height of the cantilever tip.    denotes the normal force sensor response, which is measured in 
inverse amperes. With the exception of cantilever thickness, all of these variables were readily 
obtained from either microscopy or calibrations by Baker et al. In order to calculate cantilever 
thickness, researchers used the following equation, which relates cantilever properties to the 





Because the resonant frequency is known, one can reverse calculate  . Note that this equation 
only holds for silicon-based tips, but equations for other tip materials will follow the same form. 
Following this, researchers were able to calculate strain using the equation, where    is one half 







By plotting out the resulting stress-strain curves as seen in figure 5 of their paper, Baker et al were 
able to observe only a very small region of linear deformation followed by a much larger region of 
plastic deformation, with an overall graph whose slope was monotonically decreasing. These 
results indicated that their PCL fibers underwent significant strain-softening, as is common in 
polymeric materials. Specifically, the region of elastic deformation yielded an average slope of 
approximately 28 MPa over a range of strains from 0-3%. However, the average slope for the curve 
after the yield point (seen as approximately 30% in figure 5) was approximately 3.9 MPa. 
This study primarily serves to highlight the differences between mechanical properties of the bulk 
material (i.e., Young’s modulus) and measured mechanical properties of single fibers. Of particular 
note is the differences between measured fiber rigidities, which spanned single digit MPa, and the 
literature values Young’s modulus of PCL, which can span from hundreds of MPa to single digit 
GPa. Similar experiments performed by other groups on PCL fibers with diameters in the 500 nm 
to 1 µm range have likewise resulted in a wide spread of measured rigidities, ranging from 100-
500 MPa to as high as 1-3 GPa and 3-5 GPa for reasons that are not fully understood. Although 
different strain rates and molecular weights of PCL were used for these studies, ranging from 60-
300 kDa, it is hypothesized that small deviations in strain rate or molecular weight alone are not 
enough to account for these wide discrepancies in measured tensile modulus. 
In addition, Baker et al noted that there appeared to be a dependence of mechanical properties 
on the age of the fiber31. In comparing a freshly spun fiber to an aged fiber (defined as samples 30 
days or older), researchers found that while new samples had an average strain limit of 19 ± 5%, 
aged samples had strain limits of only 8 ± 2%. This was further reflected in the measured rigidities 
of the samples, where new samples had total tensile moduli of approximately 62 ± 26 MPa, but 
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aged samples had total tensile moduli of 99 ± 84 MPa. The same phenomenon was observed for 
energy loss in a single fiber manipulation. Therefore, one can reasonably conclude from this 
experiment that for micro and nanoscale non-planar materials, measured mechanical properties 
may be different than the bulk material: processing may change mechanical properties. 
It should be noted however that the PCL fibers used by Baker et al had diameters ranging from 
440 nm to 1.04 µm. While the troughs (6.5 µm height, 13.5 µm span from ridge to ridge) represent 
length scales similar to what one would observe from a fibrous mesh of this material, the strain 
rate of the fibers was set at 300 nm/s, which may closely resemble what deformations a single cell 
attachment will cause to a single polymeric fiber. 
Euler-Bernoulli theory 
As previously discussed, the interaction between a single human T cell and an underlying mesh 
fiber will yield an estimated fiber deflection on the order of ten to one hundred nanometers. 
Because the deformations to mesh fibers are postulated to be small compared to the diameter of 
the micron-scale fibers themselves, Euler-Bernoulli beam theory presents itself as viable 
fundamental starting point for a model for mesh fiber, or beam, deflection32. Euler-Bernoulli beam 
theory, which first saw usage in mechanical engineering and design calculations for the 
construction of large structures such as Ferris wheels and the Eiffel Tower in the late 19th century, 
still sees usage today as a general, first-order estimate for the behavior of linearly elastic beams 
under various loading and support conditions, as well as beam cross-sectional geometries33. 
Regardless of load and / or support type, there are three fundamental assumptions to Euler-
Bernoulli theory that apply themselves well to the current situation. Firstly, it is assumed that the 
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application of the load does not result in significant warping of the cross-sectional area of the 
beam itself. Although this is not entirely reflective of what occurs in reality, warping of the beam 
is postulated to be minute at best, and thus will not significantly impact the resulting mechanics. 
Secondly, the cross-sectional area of the beam remains planar and perpendicular to the loading 
axis. It should be noted that this final assumption is held, even in the case of beams with irregular 
geometries. Finally, it is assumed that rotational motion around the central axis of the beam is 
negligible, or in other words, that the cross sectional areas of the beam do not rotate upon 
application of the load33. 
At its most fundamental level, Euler-Bernoulli theory relates the deflection of a one-dimensional 
beam    to the magnitude of the distributed, applied load   , where    represents the distance 
along the main axis of the beam,    is the Young’s modulus of the bulk beam material, and   
represents the moment of inertia. Note that both   and    in the general case can be seen as 
functions of   due to non-uniform loading. Furthermore, since the flexural rigidity, herein defined 
as the product of   and  , is most often times constant,  ( ) can be directly related to the fourth 











Calculation of the deflection for a given beam geometry and loading condition thus varies from 
case to case, but will generally require one to solve the fourth order differential equation above 
or a variant of it. 
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The case of a single cell residing on a beam, however, can be roughly approximated as a three-
point bending scenario. In this situation, a beam with length   as described above sits on two 
simple supports at its ends and is subjected to a single asymmetric perpendicular point force at a 
position   =   ∈ [0,  ] along its length (see figure 3). The boundary conditions in this scenario 





Figure 3: Asymmetric point loading of a beam with two simple supports 
In this case, the solution to the differential equation yields the following equations for deflection 
 ( ) given a circular cross-sectional area33: 
 ( ) =
  (   −   )   ⁄
9√3   








(   −   )   ⁄
   
  
Although a cell pushing down on a mesh fiber by itself is not a point force, we can approximate it 
as one due to the length scales of the cell and fiber involved in this situation. It should be noted 
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that in this scenario, additional assumptions, most notably that fiber slippage does not occur, were 
made on top of the fundamental assumptions characteristic of Euler-Bernoulli theory. 
Additional modifications are commonly performed on the classic Euler-Bernoulli theory model to 
allow for more accurate prediction of a material’s behavior32,33. One particularly common 
modification takes into account the shear modulus   of the bulk material, thus giving rise to the 
material length scale parameter   . This parameter relates to the microscale size effect of the 
materials being probed: higher values of   (units in meters) are indicative of how far away from 
the load can the original Euler-Bernoulli approximations reflect up to 50% of the calculated 
deformation. The material length scale parameter therefore can be viewed as a cousin of the 
persistence length in polymer physics. In this case,  ( ) depends on both the flexural rigidity as 
well as the material length scale parameter.   in this context represents the cross sectional area 
of the beam in question: 




With this in mind, the deflection  ( ) for an asymmetrically distributed non-point load becomes 
the following: 
 ( ) =





Research Question and Specific Aims 
The main objective of this thesis is to explore the effect of electrospun microfiber fiber geometry 
on perceived cellular rigidity, and ultimately, reveal how this can affect human T cell 
mechanosensing. Understanding this phenomenon is of particular importance for potential 
leverage in clinical level T cell-based adoptive immuno-therapy and for fuller elucidation of T cell 
mechanobiology as a whole. In order to fully explore this topic, this thesis proposal is divided into 
two main specific aims, each with two respective sub-aims, as detailed below. 
Specific aim 1: Create a robust platform for the ex vivo expansion of human T cells 
This platform would ideally possess several characteristics to render it suitable for the ex vivo 
expansion of human T cells. Firstly, this substrate should be non-biodegradable in order to ensure 
that residual material does not leach into the cell media and subsequently, into the final cell 
transfusion into the patient. Secondly, to further ensure the lack of activating substrate in the cell 
infusion, this platform should be readily removable from the cell culture. A manifestation in the 
form of a single continuous sheet, as opposed to an array of disjoint microbeads, would satisfy this 
demand. Thirdly, the surface area to volume ratio of this platform should be maximized in order 
to yield a similar level of functional area as compared to the clinical gold standard. Fourthly, this 
platform should be synthesized in a manner that is readily scaled to high throughput levels in order 
to facilitate its development and eventual deployment on a clinical scale. Finally, however, the 
main goal of this platform is to create high numbers of functional human T cells. Evaluation criteria 
towards this end will thus be based not solely on cell number, but also on cell activation and cell 
phenotype. The ramifications of this part of the thesis include the further development and 
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commercial realization of ACT. We hypothesize that this can be effectively done through the 
synthesis of a microfibrous PDMS-based mesh in order to simultaneously leverage T cell 
mechanosensing while satisfying the aforementioned design criteria.  To better study this segment 
of the project, we will divide this aim into two sub aims below: one focusing on the design of the 
platform itself, and one focusing on the cells produced from this platform. 
Specific aim 1a: Design, fabricate, and characterize a 3D fibrous PDMS/PCL mesh for T cell 
stimulation 
This thesis effectively builds off of the work previously performed by O’Connor et al and 
Judokusumo et al by investigating how human T cells respond to surfaces of varying rigidities in 
the 105-106 Pa range, but while also maintaining the high surface area to volume ratio 
characteristic of submicron-based activating bead platforms. Although an array of soft microbeads 
would achieve both goals, our goal is to improve upon the safety of magnetic microbead-based 
platforms by developing a platform that would be removable from the cell solution in one step. 
This would be readily accomplished through the development of a 3D electrospun microfibrous 
mesh. As a well-studied, high-throughput technique, electrospinning presents itself as a facile 
method for synthesizing our proposed meshes. Although a wide range of natural and synthetic 
polymers have been previously used in electrospinning, spanning from collagen and alginate to 
poly(vinyl chloride) and poly(urethane), the primary mesh material in this matter was chosen to 
be PDMS due to its rigidity modulatory properties through modification of the crosslinker to base 
ratio, as well as its non-cytotoxicity and non-biodegradability. However, as previous literature has 
suggested, the electrospinning of pure PDMS microfibers has yet to be accomplished, in part due 
to the highly viscous nature and organic solvent immiscibility of this polymer. To aid in the 
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electrospinning process, we herein blend PDMS with PCL, an economical, non-cytotoxic, non-
immunogenic, commercially available polymer. Although the addition of PCL to the mesh will 
undoubtedly raise the rigidity, its role as a viscosity modulator is be vital to mesh synthesis. 
Optimization of mesh spinning parameters, such as working distance, voltage, polymer feed 
concentration, and spinning rate, were necessary to tune mesh fiber geometry. In order to 
optimize cell interaction with the mesh, it was postulated that fibers with diameters greater than 
10 µm and pore sizes with diameters less than that of a resting T cell, taken as 7 µm, would not be 
optimal in promoting expansion. Previous studies on proliferation with cell types ranging from 
AFSCs30 to human fibroblasts29 have tested the effect of fiber alignment on cell growth. To test 
the effect of fiber alignment on cell activation and proliferation, both unaligned and aligned 
meshes were synthesized by the use of a stationary collection electrode or rotating drum, 
respectively. 
It should be noted that PDMS has a network polymer structure and is thus has a particularly high 
permeability to a range of small hydrophobic molecules, most significantly, gases such as oxygen13. 
As such, some applications see the use of PDMS as a modulator to determine how much gas enters 
a particular chamber or partition. On the other hand, the use of PDMS in applications such as 
microfluidics and more macroscale implants is generally avoided due in part to its ability to reduce 
oxygen concentrations in cell cultures. In this application, cells are cultured on PDMS-based 
scaffolds, however, due to the small amount of PDMS present, the effects of oxygen and other 
small molecule absorbance are hypothesized to be negligible. 
In order to maximize the surface area to volume ratio, while still maintaining adequate room for 
cell penetration into the mesh, we have synthesized both microscale and nanoscale diameter 
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fibers through the modulation of the aforementioned spinning parameters, most prominently, 
polymer concentration in the spinning feed. Pore size was also of importance, as pores with 
diameters on the same order as of a naïve T cell would be conducive towards cell penetration into 
the mesh, thus taking full advantage of the high surface area to volume ratio. Verification of mesh 
morphology was performed via SEM, however, to ensure even dispersion of PDMS and PCL 
molecules in the final fiber, Fourier transform infrared spectroscopy (FTIR) was also performed. 
Bulk rigidity values were calculated via uniaxial tensile testing and AFM measurements on casted, 
planar samples, while local fiber rigidities were measured solely by AFM. The overall goal of this 
section is thus to synthesize PDMS/PCL meshes with tunable microscale and nanoscale fiber 
diameters and pores, and we hypothesize that electrospinning will present itself as an excellent 
choice of synthesis process. 
Specific aim 1b: Evaluate the effects of rigidity modulation in electrospun PDMS/PCL meshes on 
human T cell activation and proliferation 
This section of the thesis aims to analyze how fibrous mesh properties, such as rigidity, fiber 
alignment, and pore/fiber diameter affect human T cell activation and proliferation. We 
hypothesize that better leverage of T cell mechanosensing, as realized in the formation of softer 
experimental meshes, will yield higher levels of cell proliferation while maintaining or improving 
cellular activity and maintaining cell phenotypic distributions. In order to provide T cells with the 
activation signals required for stimulation, meshes were coated with agonist antibodies to surface 
proteins CD3 and CD28: these provide the primary and secondary activation signals for T cells, 
respectively. A primary/secondary antibody capture technique were used to adhere the activating 
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antibodies to the surface of the mesh and ensure that activating antibodies will have the proper, 
upward-facing orientation.  
Isolated human T cells from whole blood from healthy donors aged 18 to 64 were then stimulated 
on these meshes. In order to prevent overstimulation and thus premature cell death, T cells were 
removed from the mesh environment after three days and allowed to continue growing in a mesh-
free environment. During this time, cell proliferation, size, and activation were monitored. Two 
key measurements of this were the proliferative index (PI), which measures the average number 
of divisions a cell has gone through, and the percent of cells entering primary division (% div). 
Upon completion of the primary blasting phase, cells were further assayed for activation and 
phenotype markers in order to determine the distribution of effector memory, central memory, 
effector, and naïve cells in culture, we were assaying for surface markers CCR7, CD45RO, and 
CD62L, in addition to the standard markers for helper T cells and cytotoxic T lymphocytes (CTLs), 
CD4 and CD8, respectively. To analyze the activation level of CD4+ cells, we were assaying for IFNγ, 
a cytokine secreted by helper T cells. Likewise, we were assaying for the expression of lysosomal-
associated membrane protein-2 (LAMP-2), or CD107b, in order to measure the activation level of 
cultured CD8+ cells. Finally, to further mimic the current model of adoptive immunotherapy, a 
subset of the total cell culture was isolated and frozen down prior to being restimulated and 
analyzed for all surface markers and cytokines.  
In addition, it has been previously noted that the Dynabead® platform has had difficulty with 
inducing the activation and proliferation of exhausted T cell populations, such as in patients 
suffering from chronic lymphocytic leukemia (CLL). In order to measure the effectiveness of our 
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mesh platform on the expansion of exhausted T cell populations, we conducted the T cell 
activation and proliferation experiment in this section with cells isolated from CLL patients of Rai 
stages 0-4 in addition to cells from healthy patients as controls. 
Specific aim 2: Develop and validate a quantitative model for mesh rigidities on a cellular scale  
Although it has been successfully demonstrated that human T cells undergo mechanosensing, as 
previously discussed, cells residing on a fibrous mesh may not perceive the underlying rigidity in 
the same manner as it would a bulk, planar surface. One analogy in this case would be that of a 
person climbing a rope ladder: although the rope is hard and rigid to the touch, a person ascending 
said ladder will most likely perceive it supple and yielding to the mechanical forces associated with 
climbing. A single cell residing on a mesh fiber will thus experience both the local Young’s modulus 
of the fiber material itself as well as the soft, macroscopic bending motion of the beam. By 
establishing a model that more accurately describes what T cells experience on a mesh, we can 
better correlate results from this experiment with existing reports in the literature on T cell 
stimulation on planar surfaces. On a broader scale, this section of the thesis aims to widen the 
understanding of T cell mechanosensing and mechanobiology as a whole. It should be noted 
however that this section of the thesis does not focus on elucidation of the precise biology of T 
cell mechanosensing: while it will yield insight into what forces the cell experiences on the mesh, 
questions such as which proteins are involved in the mechanosensing process, what the signaling 
pathway is, and what traction forces are exerted by the cell on the mesh will not be addressed. 
These questions, while important for the complete understanding of T cell mechanobiology, are 
not yet fully studied and will be addressed in future studies performed by this lab. 
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Specific aim 2a: Develop a quantitative model for mesh rigidities on a cellular scale 
The goal in this part is to explore how microscale fiber geometries impact measured rigidities and 
thus give insight into what a T cell feels when interacting with the mesh. Although AFM imaging 
can provide excellent topographical and surface geometry data, its insight into the exact rigidity 
of the material is somewhat attenuated by the fact that beam deflection and material deformation 
were non-negligible factors for a microfibrous mesh. This part of the study therefore builds off of 
the study performed by Baker et al, in part. 
To explore this phenomenon, AFM measurements on single fibers were performed with varying 
peak force set point levels (pFS) from 10-8 to 10-10 N and peak force amplitude (pFA) levels from 
10 to 200 nm. As our synthesized meshes will have rigidities in the 105-106 Pa range, we were using 
tips with relatively low cantilever spring constants (k < 1 N/m). Tip diameters were kept to a 
minimum (d < 40 nm) in order to obtain the sharpest images possible of mesh topography and 
rigidity mapping. Furthermore, we will explore how and if measured mechanical properties of 
fibers change over time by testing freshly prepared meshes alongside meshes aged three months 
or more. By combining the AFM data from material deformation, tip adhesion, tip indentation, 
and mechanics of beam bending via Euler-Bernoulli theory, we calculate out a more accurate 
measurement of what the cell is seeing on the mesh, and summarize this into a unifying model. 
Specific aim 2b: Assess the validity of the mesh rigidity model via an in vitro cell-based study 
In the final section of this thesis, we aim to validate the accuracy of our model derived in specific 
aim 2a in reflecting the perceived rigidity of PDMS/PCL meshes. To this end, a follow-up in vitro 
study was performed. In this part of the experiment, electrospinning parameters were re-tuned in 
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order to synthesize meshes with perceived rigidities on par with the planar surfaces analyzed in 
O’Connor et al’s study, most notably polymer weight concentration, working distance, and 
solution discharge rate. Specifically, mesh fibers were fabricated to yield perceived rigidities, or 
effective Young’s moduli, equal to approximately 1 MPa and 40 kPa. Human T cells isolated from 
healthy donors were once again be cultured upon these substrates as outlined in specific aim 1b, 
and additional experiments for IL-2 secretion were performed to compare with the results from 
O’Connor et al’s study. By validating this model, this experiment effectively establishes a baseline 
for rigidity measurements of microfibrous meshes in which beam bending motion plays an 






Specific aim 1a: PDMS/PCL mesh fabrication and characterization 
1.1 Mesh fabrication and functionalization 
Fibrous meshes were synthesized via co-electrospinning of NuSil MED-4086 PDMS (M4086) or 
Sylgard 184 PDMS (S184) mixed with PCL (Sigma, Mn = 80 kDa) in a 3:1 v/v solution of 
dichloromethane (DCM) / N,N-dimethyl-formamide (DMF) at 8-10 kV onto either a grounded static 
collection electrode or rotating drum with a working distance between 8-12 cm. For M4086 fibers, 
either a 1:1 or 5:2 w/w ratio of PDMS:PCL (herein termed low [PDMS] and high [PDMS] respectively) 
were used, while for S184 fibers, a 1:1 or 4:1 ratio of PDMS:PCL were used. Mesh spinning times 
were varied between 5 and 8 hours, and all meshes were allowed to sit overnight at room 
temperature prior to use. Additionally, meshes of pure PCL were electrospun as rigid controls.  
Meshes were coated with goat-anti-mouse IgG linkers (MP Biomedicals, 2 µg/mL, Cat no. 0867028) 
at room temperature for 2 h followed by a 1:4 mol/mol ratio of mouse IgG-anti-human CD3 (Bio X 
Cell, clone OKT3, Cat no. BE0001-2) to mouse IgG-anti-human CD28 (Bio X Cell, clone 9.3, Cat no. 
BE0248) at room temperature for 2 h (2 µg/mL total solution). Blocking were performed with 5% 
bovine serum albumin (BSA) (Sigma, lyophilized powder, > 96% via agarose gel electrophoresis, 
Cat no. A9418) at room temperature for 2 h. For cell expansions, meshes were secured to glass 
coverslips via a thin layer of partially cured S184 PDMS (1:3 w/w crosslinker to base ratio) (see fig. 
2). Prior to cell seeding, meshes were sterilized with an ethanol bath at room temperature (70%, 
30 min) followed by UV irradiation for an additional 30 min and drying in air for a final 30 min. 
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1.2 Mechanical and chemical analysis of meshes 
Mesh fiber and pore sizes were quantified via scanning electron microscopy (SEM) (Hitachi S-4700, 
1.5 kV). Samples were coated with a thin layer of Au-Pd via sputter coating in Argon (Cressington 
108, 12-15 s) prior to SEM analysis. Bulk and local rigidities were quantified via a uniaxial tensile 
tester (Instron 8841) and via atomic force microscopy (AFM) (Bruker Multimode 8 with QNM), 
respectively. Mesh chemistries were analyzed via Fourier transform infrared spectroscopy (FTIR-
ATR) (DigiLab Excalibur). 
Specific aim 1b: Human T cell expansions on synthesized PDMS/PCL meshes 
1.3 Patient samples 
Mixed naïve CD4+ / CD8+ T cells were isolated from whole blood derived from healthy patients 
aged 18-64 years or CLL patients currently at Rai stages 0-4 inclusive. Briefly, cells were incubated 
with RosetteSep for 25 min (5% v/v) (Stemcell Technologies, Cat no. 15061) prior to centrifuging 
(Eppendorf 5810R, 25 min, 800 x G) in Ficoll-Paque PLUS (GE Healthcare, Cat no. 17-1440-02). 
Cells were frozen in 10% v/v DMSO and kept in liquid nitrogen for up to two years. 
1.4 T cell activation and proliferation 
Prior to seeding, isolated T cells were treated with carboxyfluorescein succinimidyl ester (CSFE) 
(Thermo-Fisher Scientific, Cat no. C34554) in order to track cell division and proliferation. T cells 
were seeded onto meshes or with Dynabead® positive controls (Thermo Fisher, Human T Cell 
Activator, Cat no. 11132D) according to the manufacturer’s recommendation in a 24-well plate 
(Corning, Cat no. 3524) at a density of 1 million cells / mL and cultured for 3 days (37°C, 5% CO2). 
 
39 
Cells were removed from meshes via manual pipetting or a magnetic wand for Dynabeads®. 
Cultures were counted and reseeded at 1 million cells / mL on day 3 and every other subsequent 
day without activating substrates in a 12-well plate (Corning, Cat no. 3513) for a total of up to 19 
days. 
 
Figure 4: Mesh configuration schematic for cell expansions 
RPMI 1640 media (Gibco, Cat no. 21870-076) supplemented with L-glutamine (20 µM, Gibco, Cat 
no. 25030-081), fetal bovine serum (FBS) (5%, GE Healthcare, Cat no. SH30071), 1x penicillin 
streptomycin (Thermo-Fisher Scientific, Cat no. 15140122), and HEPES (100 µM, Sigma, Cat no. 
3784) were used for all culture steps of this experiment. 
Flow cytometry (BD FACSCANTO II, BD LSRFortessa) were performed on days 3 and 5 of culture to 
track cell proliferation and activation. Additionally, cell phenotype was determined by staining for 
surface proteins CD4, CD8, CD45RO, and CCR7. Cell size were tracked via a handheld particle 
counter (Millipore Scepter® 2.0) beginning on day 3 and every other subsequent day until mean 
cell volume dropped below 400 fL.  
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1.5 T cell restimulation and cellular activation assays 
T cells were frozen upon completion of the initial blasting phase post-primary stimulation, herein 
defined as when average cell volume dropped below 400 fL. For restimulation, cells were thawed, 
allowed to rest for 12-14 hours, and subsequently stimulated on Dynabeads® according to 
manufacturer’s recommendations. 
Cell activation were quantified through expression of CD107b (lysosome-associated membrane 
protein 2, LAMP-2) and interferon gamma (IFNγ). For CD107b, cells were thawed and restimulated 
for 4 h on Dynabeads® while for IFNγ, cells were allowed 12 h for restimulation on Dynabeads®. 
Staining were performed according to manufacturer’s recommendation (Biolegend, Clone H4B4, 
Cat no. 354304; Miltenyi Biotec, Cat no. 130-090-433, respectively). Additionally, staining for 
perforin (Biolegend, Clone dG9, Cat no. 308118) were also performed in accordance with 
manufacturer’s protocol. 
1.6 Cell exhaustion assays 
CLL patient-derived cells were stained for programmed cell death protein 1 (PD-1, CD279) 
(Biolegend, Clone 1A12, Cat no. 135214) on day 0, day 3, and every other subsequent day until 
mean cell volume dropped below 400 fL. 
1.7 Protein desorption assays 
In order to measure protein desorption, cell-free meshes were coated with goat-anti-mouse IgG 
linkers at room temperature for 2 h followed by a 1:5 mol/mol ratio of FITC-tagged mouse IgG-
anti-human CD3 (Biolegend, clone OKT3, Cat no. 317306) to non-fluorescent mouse IgG-anti-
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human CD3 (Bio X Cell, clone OKT3, Cat no. BE0001-2) for 2 h. Meshes were incubated in RPMI 
media for 2 days at 37 °C and were subjected to epifluorescence imaging at either day 0, 1, or 2 
(Olympus IX71). Microscopes were calibrated via fluorescently labeled microbeads prior to 
imaging (Inspek Green 505/515). 
1.8 Cell inhibition assays 
Cell inhibition assays were performed via addition of ROCK inhibitor Y-27632 (compound Y, 
Stemcell Technologies) to cell cultures at 5, 1, 0.5, 0.1, and 0 µM. Prior to seeding and after FITC 
treatment, cells were incubated in compound Y for 20 minutes. Subsequent cell culture days were 
carried out with the same inhibitor concentrations as on day 0, and cell proliferation recorded in 
the same manner. 
Specific aim 2a: Quantitative model for PDMS/PCL mesh rigidities  
2.1 Rigidity measurements 
Mesh surface topographies and rigidities were measured via atomic force microscopy (AFM) with 
a sharp conical tip (Bruker Multimode 8, SCANASYST-air tip, k = 0.4 N/m, d = 8-30 nm, cone half 
angle = 12-22°). Additionally, material deformation, tip adhesion, and tip deflection were 
measured. Lateral probe motion was limited to 1.0 µm/s. All AFM images were analyzed via AFM 
data processing software (Nanoscope 1.9) and subsequent curve fitting analyses were performed 
via Matlab (R2017a). 
Standard Euler-Bernoulli theory for a simply supported beam with circular cross-sectional area 
subjected to an asymmetric point force was used as the starting point for model construction.  
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Specific aim 2b: In vitro study for quantitative model verification 
2.2 Mesh fabrication and in vitro verification study 
In order to verify the model developed in specific aim 2a, fibrous meshes were again synthesized 
as previously described, but with rigidities of approximately 150-300 kPa and 2-3 MPa in order to 
align with the tested bulk moduli of the paper by O’Connor et al. Electrospinning parameters were 
held constant as in specific aim 1a, but polymer concentrations were varied from 10 to 50% total 
weight percentage, working distance varied between 4 and 10 cm, and spinning speeds varied 
between 0.5 and 1.6 mL/h with a 25 G needle. Mesh spinning times were held constant at 5-8 
hours and meshes were allowed to sit overnight at room temperature prior to use. In vitro studies 
of cell proliferation and activation were performed as previously described in methodology 
sections 1.4-1.6.  
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Results and Discussion: Specific Aim 1 
Specific aim 1a: PDMS/PCL mesh fabrication, functionalization, and characterization 
The main goal of this work is the engineering of a continuous platform that not only leverages 
mechanosensing but also retains the high surface area to volume ratio characteristic of 
microbeads. Centra7l to this is the ability to effectively tune the mesh fiber diameter and pore size 
to allow for cell penetration into the mesh matrix while maintaining a relatively soft overall 
material. As such, two key parameters that were varied alongside mesh rigidity were fiber 
diameter and fiber alignment in order to produce both micro and nanoscale mesh fibers in both 
aligned and unaligned forms. Modulation of various electrospinning parameters such as working 
distance, polymer weight concentration, and accelerating voltage allowed for the formation of a 
wide range of fiber geometries. 
The grade of PDMS utilized in the formation of the meshes presents itself as another point of 
discussion, primarily due to the fact that only certain formulations are permitted by the FDA for 
use in the body. Typical manifestations of PDMS in the human body come in the form of cosmetic 
and reconstructive implants, i.e., breast implants. While the ex vivo nature of the expansion 
process for ACT does not readily lead to dissociation of activating substrate into the cell transfusion, 
using a grade of PDMS pre-approved for use in the body will better ensure that in the occasion 
should such a dissociation occur, the potential for patient harm will be negligible. Preliminary 
experiments in mesh synthesis and cell expansion utilized the S184 formulation due to its 
commercial availability and more widespread usage, particularly as an insulating material from 
electrical currents in transformers and printed circuit boards. However, S184 is not approved for 
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use in the human body, therefore the vast majority of results discussed herein will be focused on 
meshes synthesized with MED formulation due to the widespread usage of MED formulations 
(MED-6400, MED-2174, etc.) in implants and other products designed for long-term placement in 
the body. Furthermore, PDMS/PCL meshes made with a 1:1 w/w ratio of PDMS to PCL will herein 
be referred to as low [PDMS] meshes while meshes made with a 5:2 w/w ratio of PDMS to PCL will 
be referred to as high [PDMS] meshes. Note that the prefixes low and high refer only to their PDMS 
concentration, not the rigidity of the surface. 
Electrospun aligned and unaligned M4086 fibers were found to exhibit a range of fiber diameters 
and pore radii ranging from 680 ± 290 nm to 2.28 ± 0.39 µm, and 2.51 ± 0.80 µm to 12.21 ± 3.37 
µm, respectively via SEM (see figure 5). Unaligned fibers revealed an average angle   between any 
two fibers was 35.15 + 4.17°, while aligned fibers revealed   ≈ –5.22 + 3.29°, thus indicating that 
fibers were indeed unaligned or aligned, respectively. Although well-defined fibers were observed 
to appear on the collection electrode, premature processing and utilization of these meshes 
indicated that fibers were not fully dry upon completion of spinning. As the electrospinning of pure 
PCL fibers do not normally give rise to this phenomenon, this wetness may indicate that submicron 
level PDMS units do not undergo crosslinking with solvent evaporation, but with lower levels of 
heat and time as well. In this experiment, nanoscale and aligned formulations were found to yield 
meshes with lower fiber diameters and pore sizes than their microscale and unaligned 
counterparts, respectively. Notably, significant differences in pore size, fiber diameter, and overall 
fiber morphology were not detected between S184 and M4086 PDMS meshes: on average, fiber 
diameter and pore sizes differed by less than 14%, with no formulation being consistently higher 




Figure 5: SEM images of aligned (top) and aligned (bottom) M4086 meshes at varying ratios of 
PDMS:PCL (w/w), along with average fiber diameters and pore radii (n = 4). All images are taken 
at 500 X magnification. Higher concentrations of PDMS were observed to lead to non-fibrous mesh 
formation, as seen in the 4:1 nano formulation. 
Microscale M4086 meshes were found to have fiber diameters on the order of 1-3 µm and pore 
sizes on the range of approximately 9-12 µm. Pure PCL meshes exhibited pore sizes and fiber 
diameters similar to those of other PDMS/PCL meshes. While high [PDMS] meshes tended to have 
larger fiber diameters and pore sizes than their low [PDMS] counterparts, this difference was less 
than 20% and thus was not considered to be significant factor in this experiment.  
Ideally, we are looking for the mesh with the lowest possible PCL concentration, as its stiffness 
adds undesired rigidity into the mesh mechanical properties: mixing just a hair of PCL would thus 
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be ideal, as it ensure that one retains the viscosity-modulatory properties while minimizing rigidity. 
However, as seen from our experiment, (see figure 5), attempts to make 3:1 or 4:1 w/w PDMS/PCL 
meshes did not yield promising results. At the 3:1 ratio, fibers were seen to start to blend together. 
This became more prevalent at the 4:1 ratio where in lieu of steady electrospinning, the polymer 
feed would fly in macroscopic, intermittent blobs towards the collection electrode. This effectively 
let to the formation of a polymer mat with low pore sizes and irregular structure (see figure 5), 
rather than a mesh. Without sufficient levels of viscosity modulator present in the polymer feed 
to counterbalance the high levels of PDMS, the feed became unsuitable for electrospinning. 
As the average diameter of a naïve human T cell is approximately 7 µm12, it was hypothesized that 
pore sizes on the order of 9-12 µm would be optimal for cells to burrow into the mesh as opposed 
to nanoscale and aligned meshes, which featured pore sizes of approximately 2-5 µm. This would 
allow cells to fully take advantage of the high surface area to volume ratio characteristic of fibrous 
meshes. To confirm this, epifluorescence microscopy was conducted on meshes coated with a 1:5 
mol/mol phycoerythrin (PE)-stained OKT3 / non-fluorescently tagged OKT3 at six hours post-
seeding with isolated human T cells with a FITC-phalloidin stain for actin (see figure 6A). The 
resulting images confirmed that cells were interacting with the mesh and penetrating into the 
mesh matrix at depths up to 30 µm. As synthesized meshes were measured to have thicknesses 
of up to 120 µm, this indicated that there may be other forces preventing the complete 
penetration of cells into the mesh, such as the seeping of the PDMS glue layer up into the mesh 
during the mounting process, and / or the lack of penetration of activating antibodies into the 
mesh matrix. PDMS and PCL are notably hydrophobic molecules and while antibody adsorption 
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onto these surfaces will be an energetically favorable interaction, their dispersal in cell media, an 
aqueous medium, may not fully promote this adsorption.  
It should be noted that while PCL is fully miscible in DCM and DMF, PDMS is not fully miscible in 
either. According to previous reports published by Lee et al in 200335, PDMS is most miscible in 
secondary and tertiary amines such as diisopropylamine and triethylamine, as well as slightly polar 
organic solvents such as diethyl ether. On the other hand, it is least soluble in alcohols (i.e., 
propanol, glycerol, etc.), di-substituted amines such as DMF, and water; essentially, organic 
solvents with moderate to high dipole moments (defined as   > 1.4   ). Therefore, it is not 
feasible as of this writing to simultaneously force both PDMS and PCL into a perfect solution in 
DCM and DMF. An emulsion, formed by the incomplete but uniform dispersal of PDMS in a PCL-
DCM/DMF solution was thus used as the electrospinning feed. To boot, emulsions were observed 
to phase separate if left static on a flat surface overnight, although emulsions were not observed 
to separate over the course of a single electrospinning session, i.e., 5-6 hours. Therefore, one key 
insight was to determine the level of dispersal of PCL in PDMS. 
Chemical analysis of fibers via FTIR and correlation with the literature on the PDMS spectrum 
confirmed the presence of both PCL and PDMS peaks in the mesh (see figure 6B). This notion was 
later supported by AFM data, which will be fully discussed in a later section. AFM data revealed a 
relatively uniform local rigidity across the body of mesh fibers free of pockets of abnormally high 
or low rigidity, thus indicating that phase separation of PCL and PDMS was negligible during the 
electrospinning and drying process. As both S184 and M4086 meshes yielded very similar results 
in terms of physical properties and ease of electrospinning, the remainder of this report will 
primarily focus on M4086-type meshes due to its approval for use in the human body. 
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Figure 6: (A) T cell (green, FITC-actin) penetration and interaction with M4086 unaligned 
microscale low [PDMS] mesh fibers (red, PE-OKT3) at 20 X and 100 X magnification six hours post-
seeding (left and right, respectively). (B) FTIR analysis for PDMS/PCL and pure PCL meshes. Note 
the presence of the characteristic PCL peak at 1728 cm-1 in all samples but lack of PDMS peaks in 
the pure PCL sample. 
Functionalization of the mesh with primary capture antibodies and secondary activation 
antibodies via direct adsorption as previously performed by O’Connor et al. allowed for the proper 



























mesh for three days, a lack of protein desorption from the mesh into the cell media is of particular 
importance in order to prevent overstimulation and to ensure a safer transfusion to the patient. 
In this part of the experiment, meshes were coated with goat-anti-mouse IgG linkers at room 
temperature for 2 hours followed by another 2 hours with a 1:5 mol/mol ratio of FITC-tagged to 
non-fluorescently tagged OKT3 to approximate the primary / secondary antibody stack used on 
the meshes for expansion.  
 
Figure 7: Protein coating concentration and desorption on days 0-2 inclusive (n = 3), normalized to 
the average protein concentration. All error bars mean ± standard dev. 
Measurement of protein desorption across three days revealed a minimum of 80% antibody 
retention, thus suggesting minimal protein loss during the activation period (see fig. 7). 
Furthermore, protein desorption profiles were not found to differ significantly between mesh 
types, thus indicating that it is not protein adsorption concentration that is driving any differences 
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that although this was achieved without the usage of a covalent linking molecule scheme (i.e., 
biotin and streptavidin), future work, as discussed in the final sections of this thesis, will focus on 
development of such a linking strategy to ensure a safer patient transfusion. 
Specific aim 1b: Evaluate the functionality of PDMS/PCL meshes via T cell expansions 
Central to the clinical adoption of a platform for T cell based ACT is the ability to produce optimal 
amounts of active, viable T cells. According to recent papers, the benchmark of approximately 50 
million cells per infusion has been postulated as the minimal amount. It should be noted that in 
healthy individuals, naïve T cells occur at a rate of approximately 1 million cells per mL of 
unprocessed whole blood. In patients suffering from certain maladies, such as early-stage 
leukemia, this number often times decreases due to the overproduction of other types of cells. In 
this case, early stage leukemia patients’ immune systems are flooding the blood with large 
amounts of inactive, defective B cells, thus lowering the T cell concentration per unit volume13. 
Furthermore, the withdrawal of large amounts of blood from elderly patients and patients 
suffering from acute illnesses may often be undesired. Since excess cultured cells can always be 
frozen down and stored for future transfusions, it is in the best interest of the patient and the 
clinic to be able to produce as many cells as possible from a starting population while maintaining 
high levels of cell activation. 
In order to have a viable cell transfusion however, cells must be both active and have the proper 
phenotypic distribution. Cell activity for non-regulatory T cells can be broadly concerns the 
production of cytokines such as IL-2, IFNγ, TGF-β, etc. by CD4+ cells and the expression of cytotoxic 
surface markers such as CD107a (LAMP-1) and CD107b (LAMP-2) by CD8+ cells. While the 
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production of regulator T cells via ACT may prove useful in the treatment of autoimmune diseases, 
the development of such therapies are outside of the scope of this project and thus, we did not 
aim to produce high levels of Tregs from isolated naïve T cells. As previously stated in this report, 
the production of both effector memory and central memory T cells, as opposed to non-memory 
type T cells, were of particular interest to us since secondary stimulation of the adaptive immune 
system is mostly driven by memory cell subtypes rather than shorter-lived effector cells. 
Long term cell culture for 19 days revealed similar growth patterns in both mesh and Dynabead®-
expanded cells, with a primary blasting phase lasting anywhere between 7 and 11 days before 
returning to rest, as measured by cell volume (see fig. 8A). During this primary blasting phase, cells 
from all mesh and bead cultures were seen to undergo rapid division, as evidenced through the 
formation of cell clusters in solution. In order to gain an accurate perspective on cell volume, all 
particles with volume less than 200 fL (that is, the volume of a naïve T cell) were gated out as cell 
debris. Notably, cell debris was commonly observed in all mesh and bead cultures during the 
blasting phase. Cell volume typically peaked at day 5 at approximately 700 – 900 fL, although there 
was a small variation between cultures: some cultures would experience peak cell volume at day 
7 instead of day 5, but during the course of this project, it was never observed that this peak 
happened anywhere before day 5 or after day 9. In contrast to mesh and bead cultures, negative 
control cultures, which comprised of isolated naïve T cells being seeded onto a planar polystyrene 
cell plate without the addition of cytokines or antibodies, did not experience growth throughout 
this period: cell populations typically reached near-zero figures after seven to nine days. This was 
expected, as without stimulation of the TCR, T cells are programmed to undergo apoptosis.  
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A key observation in this experiment was that improved cell expansion on PDMS/PCL meshes over 
pure PCL meshes and Dynabead® controls was achieved (see fig. 8B). Specifically, low [PDMS] and 
high [PDMS] meshes yielded approximately 9.4 ± 0.6 and 9.8 ± 0.6 maximum doublings, 
respectively, compared to 6.1 ± 0.9 and 7.3 ± 1.1 maximum doublings for pure PCL and 
Dynabeads®, respectively, thus implying that the mesh platform has the potential to produce 
upwards of 5.6-12.5 times more cells than the clinical gold standard. Although cell proliferation 
levels for both low and high [PDMS] meshes were significantly different from PCL meshes and 
Dynabeads® (p < 0.05, one-way ANOVA), there was not a significant difference between the low 
and high [PDMS] meshes themselves. This may likely be due to a relative similarity in rigidity levels 
(1:1 w/w compared to 2.5:1).  
 
Figure 8: (A) Average cell volume (n = 4) from days 0-13 on select unaligned M4086 meshes. Cells 
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Figure 8 (continued): (B) Cell proliferation across days 0-19 (n = 8) on (UN)aligned meshes. (C) Cell 
activation level as quantified via %div and PI for expansions on (UN)aligned or (AL)igned meshes 
with (µ)scale or (n)anoscale fibers. All p-values are for one-way ANOVA. *, ǂ p < 0.05 compared to 
PCL, Dynabeads® respectively; **, ǂǂ p < 0.01 compared to PCL, Dynabeads®, respectively. All 
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In each pair of unaligned and aligned meshes, unaligned meshes consistently outperformed the 
aligned ones in terms of population doublings. This may be attributed to the significantly higher 
fiber density and lower pore size as previously noted in the table in figure 5. This cramped 
structure was postulated to inhibit cell penetration into the mesh matrix and full leverage of the 
high surface area to volume ratio. To this end, fluorescent microscopy images of protein 
concentration revealed that nanoscale meshes had the lowest protein penetration of all meshes, 
with a strong protein signal lasting only approximately 12-15 µm into the mesh.  
Cellular activation was quantified at day 3 through two different measurements: the number of 
cells entering primary division (%div), and the proliferative index (PI), herein defined as the 
average number of divisions an average cell has undergone and with a calculation formula as 
previously discussed. Although Dynabead®-expanded cells were observed to have a significantly 
higher %div, experimental mesh-expanded cells, particularly ones expanded on low [PDMS] 
meshes, were seen to have significantly higher PIs. Specifically, while Dynabeads® cultures 
attained anywhere from 19-35% higher %div than experimental mesh cultures, low [PDMS] mesh 
cultures outperformed Dynabeads by 0.1 to 0.2. This indicated that while PDMS/PCL meshes may 
slightly less conducive towards stimulating naïve T cells into primary division, those that do get 
stimulated become significantly more activated than their Dynabead®-activated counterparts. 
Notably, PI does not scale linearly, therefore, an n% increase in PI will correspond to a higher 
percentage of cells entering higher levels of division. Furthermore, experimental meshes 
demonstrated significantly higher values for both PI and %div than rigid control meshes, thus 
indicating that softer substrates may provide for better activation of naïve T cell populations. 
Additionally, microscale fibers were seen to yield slightly higher numbers of doublings than 
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nanoscale fibers. Due to this and the relative ease of making unaligned fibers compared to aligned 
fibers, studies performed herein will primarily focus on the use of microscale, unaligned PDMS/PCL 
meshes as the experimental substrates. 
It should be noted that the higher %div reported for Dynabead®-cultured cells may be due in part 
to difficulty in separating stimulated cells from the underlying mesh. Currently, this is done via 
mechanical pipetting motions on day 3 of culture. Although we have observed cells to naturally 
detach from the mesh after four days of culture, cells were removed on day three in order to keep 
protocols consistent with the Dynabead® protocol, and cells that have penetrated the mesh 
further may still remain even after washing. Therefore, a more efficient removal method may lead 
to the release of more cells that have been induced into undergoing primary division but still 
maintain a high affinity for the mesh. 
To further evaluate the functionality of mesh and bead-stimulated cells, cells were harvested from 
culture after returning to rest as measured by cell volume. The current model for adoptive 
immunotherapy has expansion facilities and bioreactors separate from the clinics themselves due 
to the high costs associated with setting up and maintaining these facilities: cells are harvested 
and frozen down prior to being transported between expansion facilities and clinics. In order to 
mirror the current model therefore, cells were frozen down and stored for at least one day in 
liquid nitrogen prior to being thawed and restimulated for functionality assays. Restimulation 
assays in CD8+ cells revealed similar expression levels of CD107b, a surface marker for cytotoxicity, 
across both mesh and Dynabead®-expanded cells, with all groups exhibiting approximately 70-80% 
expression. Similarly, assays in CD4+ cells for IFNγ secretion, a key cytokine for the activation of 
immune cells, showed a similar pattern, with no significant difference noted across experimental 
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or control groups at 75-85% expression (see figure 9A). It should be noted, however, that 
secondary stimulation appeared to be necessary to inducing our reported levels of cellular 
activation: cells that were harvested, frozen, thawed, but not restimulated only showed only 10-
25% for both CD107b expression and IFNγ secretion across all groups, most of which can be 
attributed to background staining. This was not unexpected, as unstimulated, circulating memory 
T cell phenotypes do not become activated until seeing target antigen a second time. 
Phenotypic assays likewise revealed a similarity in cell phenotype after restimulation, particularly 
in terms of central memory and naïve cells after cultures returned to rest. In general, all culture 
groups were observed to be primarily composed of central memory cells, with 60-80% of the 
population showing markers for both CD45RO and CCR7 (see figure 9B). As previously observed 
with CD107b expression and IFNγ secretion, restimulation was necessary to see this shift in cell 
phenotype, as without restimulation, only 20-40% of the population were observed to be central 
memory cells. Naïve cell populations on the other hand were observed to be a minority all 
throughout, although upon restimulation, populations tended to drop from 15-40% to 0-10%. This 
phenotypic distribution data coupled with the results of the restimulation assays confirm that 
while experimental meshes yield higher numbers of cells from the same starting population, the 
phenotypic profile remains constant and the level of cell activation upon restimulation remains 
unchanged. It should be noted that again, there was no significant differences observed between 






Figure 9: (A) IFNγ secretion and CD107b expression levels (n = 4) with and without restimulation. 
(B)  Central memory (CM) and naïve cell populations with and without re-stimulation (n = 4). All 











































CLL patient cell expansions 
Experiments that have been discussed up to this point have focused on the use of naïve T cells 
isolated from healthy human donors aged 18-64. However, patients that are best suited for ACT 
tend to be suffering from chronic illnesses. Therefore, in order to fully explore the functionality of 
the mesh platform, T cells isolated from CLL patients were expanded and evaluated for activation 
and proliferation. It should be noted that although a wide range of chronic illnesses can potentially 
be treated by ACT, CLL was chosen for this experiment due to its prevalence in prior studies on 
the uses of ACT. The progression of CLL can be best divided into different stages as described by 
the Rai classification or Binet classification schemes. Most commonly used in European countries, 
the Binet scale classifies patients by both the number of compromised lymph tissue groups, i.e., 
spleen, liver, and neck lymph nodes, and the rarity of erythrocytes and platelets in the blood. 
However, for this report we will be using the Rai staging system. Most commonly used in the 
United States, the Rai staging system breaks up patients into five categories from stage 0 (least 
severe) through 4 (most severe) inclusive. 
The baseline threshold for CLL diagnosis is commonly taken to be monoclonal lymphocytosis, in 
which at least 5 000 monoclonal B cells per microliter of blood. In Rai stage zero, lymph nodes and 
lymph organs appear normal. However, as the Rai stage increases to 1 and 2, the lymph nodes, 
and the spleen become engorged, respectively. Rai stages 3 and 4 are subsequently characterized 
by additional anemia and thrombocytopenia, respectively, on top of the enlarged lymph organs. 
Only about 10-15% of all CLL patients are in stages 3 and 4, and furthermore, since the average 
age at diagnosis is 71 years in the United States, the immune systems of Rai stage 3 and 4 patients 
are particularly vulnerable36 and may benefit from ACT. Common to patients of all Rai stages 
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however is the prevalence of exhausted T cell populations as seen through the expression of PD-
1 on the surface of the cell. Notably, cell populations showing elevated levels of PD-1, coming from 
repeated stimulation of the adaptive immune system against overproduced non-functional B cells, 
have been shown to not be consistently expandable with the Dynabeads® platform.  
Cell proliferation and activation experiments conducted with CLL patient-derived naïve T cells on 
low [PDMS], high [PDMS], pure PCL, and Dynabead® stimulating surfaces in the same manner as 
their healthy counterparts revealed a similar overall growth pattern in which cell populations that 
responded to treatment underwent a blasting phase followed by returning to rest, regardless of 
the rapidness of division. However, in certain populations, particularly those at higher Rai stages, 
this blasting phase was prolonged for longer and at lower intensities than observed in healthy cells, 
with some cultures blasting for up to 13 days but achieving lower levels of max doublings. Certain 
cell populations generally did not respond well to treatment: in one particular patient, low [PDMS] 
meshes achieving only 1.4 doublings, Dynabeads® achieving 0.81 doublings, and pure PCL meshes 
achieving 0.96 doublings. This was further echoed in low values of PI and %div, although these 
cultures, although the vast majority of cells died after day 3, a small, active population underwent 
division. This phenomenon was relatively uncommon: of the 24 patients reported in this thesis, 
only three patients were seen to exhibit low levels of cell proliferation across all substrates. 
Importantly, in all patients, regardless of expansion profile, a trend towards higher proliferation 
and activation on softer substrates within each Rai stage was observed. Additionally, maximum 
doubling levels were observed to drop across each Rai stage within the same substrate type (see 
figures 10A and B). Specifically, cells from Rai stage 0 patients were able to attain upwards of 6.39 
+ 0.79 maximum doublings (approximately 83.86 times the starting population of cells) on low 
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[PDMS] meshes, a value that does not differ greatly from the expansion of healthy patient cells. 
As Rai stage increases, this value drops to 5.62 + 0.24, 5.89 + 0.96, and 4.84 + 0.26 doublings in 
Rai stage 1, 2, and 3 patients respectively, and to just 3.09 with Rai stage 4 patients. Although a 
downward trend was not perfectly observed, due to the fact that average max doublings in Rai 
stage 2 patients is marginally higher than that in Rai stage 1 patients. Due to the small margin of 
difference and relatively low sample size (n = 5 and 6, respectively for Rai stages 1 and 2), this was 
attributed to experimental error. Notably, only five of the patients from our sampling were at Rai 
stages 3 and 4 at the time of blood withdrawal due to the rareness of these patients overall. 
Although the power of this study was hampered by this phenomenon, a trend towards lower levels 
of cell proliferation in higher Rai stages can nonetheless be observed. It should be noted that cells 
from healthy patients were expanded alongside CLL cells in these experiments in order to serve as 
controls. For both isolations from whole blood and frozen PBMCs, staining for CD3 post-isolation 
revealed a purity of over 93 percent (data not shown), thus indicating that these were indeed T 
cells that were being expanded. 
This difference in maximum doublings became greater with increasing substrate rigidity: Rai stage 
0 cells attained an average of 4.2 maximum doublings on Dynabeads®, compared to only 0.8 with 
Rai stage 4. Still, PDMS/PCL meshes outperformed Dynabeads® and PCL control meshes at every 
Rai stage, thus implying a higher level of cell proliferation for CLL patient-derived T cells on softer 
substrates. This of particular note in Rai stage 3 and 4 patients, where experimental meshes were 
observed to yield upwards of approximately 3.1 to 4.2 more doublings, or 8.5 to 18.3 times more 





Figure 10: (A) CLL patient-derived T cell expansions. Solid lines denote Rai stage 0 and dashed 
lines denote Rai stage 3. (B) Maximum doublings for CLL expansions. Substrates are ordered 
from softest (dark) to most rigid (light). Stage 3 samples had n = 3 except for high [PDMS], where 











































Figure 10 (continued): (C) PI for CLL expansions. All error bars mean ± standard dev. 
However, significant variation was observed both between patients from different Rai stages, and 
between patients of the same Rai stage, as reflected in the error bars in figure 10. This level of 
patient to patient variability would inevitably be reduced by expanding more patient cells. This 
trend towards higher cell proliferation on softer substrates was mirrored in cellular activation, 
where PI levels were observed to reach upwards of 1.63 in Rai stage 0 cells on high [PDMS] meshes 
compared 1.49 on Dynabeads® (see figure 10C) Similarly, Rai stage 3 cells were observed to attain 
PI levels of approximately 1.42 on high [PDMS] meshes, compared to 1.20 and 1.35 on PCL meshes 
and Dynabeads®, respectively. Secondary stimulation assays for IFNγ secretion in CD4+ cells and 
CD107b surface expression on CD8+ cells again showed comparable activation levels for re-
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However, this level of variation may also imply that perhaps other factors or a combination of 
other factors are at play in determining how a CLL patient T cells respond to ex vivo stimulation. 
This is not of particular surprise due to the various differences in cell biology that are observed in 
CLL patients, such as genetic mutations and surface marker expression. Further discussion on this 
topic can be found in the conclusions and further directions section of this thesis. Ideally, a study 
would be performed evaluating the activation and proliferation of cells from a single CLL patient 
multiple times in order to evaluate intra-patient variability. Unfortunately, this was not practical 
in this experiment due to the limited quantities of blood and extremely limited quantities of PBMCs 
available from these patients, as well as the fragility of these cells. As patient schedules for 
bloodwork in the clinic are widely variable, patient deaths may occur, and patients may choose to 
move out of the region, we were not guaranteed that a patient would return to the clinic at a later 
time point. Additionally, treatment regiments for CLL, such as the use of monoclonal antibodies or 
other drugs, may have affected this study. Furthermore, depending on the severity of the disease, 
certain patients would only come to the clinic every half year or every full year. Nonetheless, in 
spite of these drawbacks, this section of our study indicates that experimental PDMS/PCL meshes 
hold significant promise for the ex vivo expansion of T cells from patients suffering from chronic 
illnesses such as CLL, and if further developed, can potentially become a driving force for 




Results and Discussion: Specific Aim 2 
Specific aim 2a: Quantitative model for PDMS/PCL mesh rigidities 
Central to the notion of T cell mechanosensing is how a cell interacts with the underlying substrate. 
While we have actively demonstrated the correlation between cell activation, cell proliferation, 
and substrate rigidity, precise measurement of what the underlying mesh rigidity is required for 
full understanding of what forces the cell experiences. Bulk rigidity measurements (i.e., uniaxial 
tensile testers) are not ideal for full elucidation of this phenomenon due to the underlying fibrous 
geometry of the mesh itself. Furthermore, due to the geometry of the mesh, the rigidity that cells 
respond to may not be the local rigidity of the material itself, but deformations experienced on a 
more macroscopic scale. As previously discussed, back-of-the-envelope calculations using simple 
structural mechanics reveal that a single cell acting as a point force on a beam with single micron-
diameter beam made of soft elastomeric material will produce significant beam deflections   
anywhere up to approximately 240 to 350 nm. Seeing as SEM images have revealed fiber 
diameters on experimental meshes to be approximately 1-2 µm in diameter, this deformation 
represents a significant 17 to 20% of the fiber diameter. Therefore, the overall perceived, or 
effective, Young’s modulus      of the mesh may very well be different than the Young’s modulus 
of a slab of the mesh material, or even the local rigidity itself. As mentioned previously, this can 
be compared to climbing a rope ladder: while single hemp fibers are rigid to the touch, a person 
climbing said ladder will feel significant give and flexibility in the overall rope structure. A fibrous 
mesh also introduces various other factors not typically considered in traditional beam-bending 
mechanics such as the traction forces between individual fibers, the non-uniform lengths and 
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diameters of fiber segments, the supporting force of fibers below the top surface, and the 
adhesion forces stemming from of the nature of the material itself. 
As of this writing, there has not yet been a fully studied, unifying model detailing the effective 
Young’s modulus of single micron mesh fibers that takes these additional factors into 
consideration. Euler-Bernoulli theory presents itself as viable starting point however; such a model 
would be of particular use to this project as it would allow one to more precisely calculate how 
well the results of this experiment correspond to previous experiments detailing the effect of the 
rigidity of planar PDMS surfaces on T cell expansion. In other words, it could yield valuable insights 
into why the cells exhibited the behavior observed during expansion experiments, although the 
exact mechanisms of T cell force sensing, i.e., which proteins are involved, what traction forces 
are exerted, and what the signaling cascade is, are not yet fully studied and is currently being 
studied by this lab. Although the addition of PCL to the PDMS undoubtedly increases the material 
Young’s modulus, the role of fiber geometry may indeed make the fiber appear less stiff than this 
figure. Therefore, we hypothesized that given a fixed material composition, one can formulate a 
model for the effective Young’s modulus as a function of fiber geometry parameters such as length 
and radius via modifications performed on fundamental Euler-Bernoulli theory. 
In order to accurately probe mesh rigidity at the nanometer scale, experiments in measuring mesh 
rigidity were conducted via AFM, which through a series of fixed complex equations and 
calculations can translate movement of a mounted tip into values for local Young’s modulus, tip 
adhesion, and surface deflection, among other values. As previous experiments have indicated, 
AFM tip geometry may have a significant impact on the topological maps received. Although a 
naïve T cell can be roughly approximated as a 7 µm diameter sphere, spherical AFM tips of that 
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size may readily get trapped in the mesh pores themselves, thus rendering AFM imaging 
impractical. Furthermore, tip diameter is inversely proportional to AFM image resolution, as one 
can probe more points per unit area with a smaller tip. Additionally, tip cantilever should also be 
taken into consideration, as stiffer cantilevers (k > 10 N/m) may not produce sufficient deflection 
when probing softer surface. On the other hand, using a soft cantilever on a rigid surface may not 
produce sufficient material deformation to generate an accurate topological image or measure 
mechanical properties. As an AFM is typically designed for analysis of a wide range of materials, 
ranging from rigidities single digit pascals to gigapascals, a wide range of cantilever stiffness levels 
are available. With this in mind, for this project, sharp AFM tips with diameters between 5 and 17 
nm with low cantilever spring constants for greatest measurement resolution and accuracy (cone, 
d < 30 nm, k = 0.4 N/m), were used. Notably, all AFM experiments were performed in air. Although 
cells are expanded on the mesh in an aqueous environment, AFM experiments in liquid may not 
yield significant difference in measured values. This is particularly true of PDMS/PCL meshes since 
both materials are hydrophobic, do not readily degrade in water over the course of several weeks, 
and do not swell or shrink significantly, such as in the case of hydrogel systems. Peak force setpoint 
(pFS) levels in this experiment, defined as the maximum force level exerted on the substrate, were 
kept in the single digit to tens of nN range in order to mirror forces exerted by cells on surfaces. 
Tapping mode was used in lieu of contact mode in order to prevent tip damage and degradation, 
and in order to focus on our best performing meshes, this experiment analyzed unaligned micro 
PDMS/PCL meshes in both low [PDMS] and high [PDMS] formulations. Additionally, microscale 
pure PCL meshes were analyzed due to their previous use as controls in the expansion experiments, 
and calibration was performed with the softest substrate available, a 2.5 MPa PDMS slab. 
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Initial topological AFM images supported fiber geometries previously derived from SEM images. 
With this technique, high [PDMS] and low [PDMS] meshes were revealed to have rigidities ranging 
from 640 ± 140 kPa to 1.24 ± 0.32 MPa, respectively, compared to 46.4 ± 14.8 MPa for PCL meshes 
(see figure 11). While Dynabeads® were not measured for this experiment, rigidities were 
estimated to be approximately 1.9-2.9 GPa according to the literature values for poly(styrene). 
Due to the lack of sudden rigidity shifts or extraneous beading in the rigidity and topographical 
mapping, respectively, fibers were concluded to be homogeneous and devoid of PDMS or PCL-rich 
regions: phase separation of precursor polymers was not observed. 
In addition to high [PDMS], low [PDMS], and PCL meshes, aged low [PDMS] meshes were analyzed 
in order to evaluate what, if any, changes in rigidity may occur at prolonged timescales. This was 
of particular interest to us for further development of this mesh as a viable commercial platform, 
as the shelf life of products need to be taken into consideration prior to marketing: an increase in 
rigidity over time would imply that meshes may not retain their functionality over longer 
timescales. In this experiment, low [PDMS] meshes aged nine months at room temperature in a 
dark location were used as old low [PDMS] meshes. Interestingly, aged experimental meshes were 
seen to exhibit slightly higher rigidities than their freshly spun counterparts: old low [PDMS] 
meshes were found to have average fiber rigidities of 14.7 ± 5.06 MPa, amounting to an almost 
ten-fold increase in stiffness compared to a freshly spun low [PDMS] mesh. While expansions have 
not yet been carried out on aged PDMS/PCL meshes in order to evaluate any decrease in cell 
stimulation efficacy, this may have further implications for clinical adaptation of this technology 
due to the time-dependent nature of measured rigidity 
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One notable phenomenon observed when evaluating mesh rigidities was how fiber position 
qualitatively appeared to have an effect on measured rigidity. This is demonstrated in figure 11A, 
where areas of strong mutual fiber support (i.e., the upper right hand corner of the high [PDMS] 
image) appear significantly more rigid (white) than areas where fibers are string between two focal 
points (i.e., center of the vertical transverse fiber in the same image). A similar phenomenon can 
be seen in figure 11B, in which areas where fibers are bundled on top of each other (i.e., the middle 
of the vertical fiber cluster) appear to have higher rigidities than both the surrounding fibers and 
areas of the same fiber that are further away from the cluster 
.  
 
Figure 11: Topographical (left) and rigidity mapping (right) for (A) high [PDMS] and (B) low 






Figure 11 (continued): (C) Average measured fiber rigidity for high, low, and old M4086 meshes, 
along with PCL. Figures represent averages over n = 6 scans. 
As the applied AFM tip force was kept in the single digit to tens of nN range for initial rigidity 
experiments, this data implied that fibers were responding to nanoscale forces of this magnitude. 
In order to further investigate how applied nanoscale forces affect rigidity, follow-up experiments 
focused on modulating the peak force set-point (pFS), or the maximum allowable tip indentation 
force from the AFM, and observing any effect on measured rigidity. This appeared to be indeed 
the case: as seen in figure 10, as one raised the pFS from 4 to 40 nN on a single aged low [PDMS] 
mesh the average fiber rigidity was seen to spike from 13.38 ± 0.57 MPa to 32.16 ± 1.94 MPa. A 
similar phenomenon was also observed with both aged high [PDMS] and pure PCL meshes, thus 
indicating that this phenomenon may be more characteristic of the substrate geometry and 
synthesis process rather than the bulk material itself. As the pFS was increased, a quadratic 
relationship between E and pFS was observed (see fig. 10B), thus further implying that simple 




























pFS from 40 nN back to 10 or 4 nN reflected lower measured rigidities. This reversibility implied 
that the increase in measured rigidity was not the result of multiple scans over the same line, but 
was primarily due to the pFS. 
 
Figure 12: (A) Rigidity dependence on pFS for a single aged low [PDMS] mesh. All images 2 µm x 2 
µm. (B) Measured rigidities in aged low [PDMS] mesh as a function of pFS. Error bars mean ± 




















Figure 12 (continued): (C) Substrate deformation as a function of distance and pFS along identical 
paths on a single aged low [PDMS] fiber. Lighter lines denote lower pFS values. 
In an ideal Hertzian model, substrate deformation, herein defined as the vertical distance moved 
by a single point on the mesh upon probing with the tip, would be zero as there is a perfectly 
elastic interaction between tip and substrate37. Substrate deformation was observed in this case 
to at points be approximately 90 nm, or approximately 7.5% the average fiber diameter, thus 
indicating again that a typical Hertzian contact model is not ideal for analyzing the surface of these 
meshes. Substrate deformation was also seen to vary with applied force: as one increased the pFS 
from 4-40 nN, substrate deformation was seen to steadily increase along the same path. Reverting 
to a lower pFS after scanning at a high pFS once again showed a similar substrate deformation 
curve as previously measured, thus again indicating that due to the reversible nature of this 

































As a result of experiments on the effect of pFS on AFM-reported rigidity, deformation was 
postulated to be a function of applied force  ( ) composed of two primary components: Hertzian 
contributions, in which   scales with the square root of applied force, and force contributions from 
the cantilever beam motion itself, in which   scales linearly with  . This is notably different than 
standard AFM models, in which Hertzian contributions are dominant in   . Therefore, we 
hypothesized that a more accurate function of  ( ) would take the following form, where a, b, 
and c are constants: 
      =    +  √  +   
Ideally, the linear offset c would be zero, however, due to experimental error, this will almost 
certainly not be the case. The is also notably different from standard Hertzian AFM models in 
which  ( ) =  √  +  , i.e., where cantilever contributions are not considered. 
In order to determine the mesh-specific constants a, b, and c, the average deformation at fixed 
pFS values were calculated. This was done by taking repetitive scans of the same mesh region and 
calculating the average fiber deformation in z (that is, parallel to the axis of AFM tip indentation), 
and performing curve fitting to both the classic Hertzian model as well as our cantilever-inclusive 
model. Percent reduction in the sum of residual squares between the data points and the fitted 
curve Σ(  ) were then calculated in order to quantitatively determine how accuracy was gained 
by the addition of the cantilever term. As seen in figure 13, the addition of the cantilever term did 
increase the deformation model accuracy in freshly spun low and high [PDMS] meshes, although 
this difference was minute and not considered statistically significant as determined by the Wald 
F-test. However, the opposite was observed for pure PCL and old low [PDMS] meshes, with a 26.5% 
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(p < 0.05, Wald F-test) and a 30.1% increase in accuracy (p < 0.01), respectively. This discrepancy 
between the increase in accuracy between softer and stiffer meshes was largely in part due to the 
wide spread of deformation values at pFS = 20 nN, which produced substantially larger values for 
Σ(  ). 
 
Figure 13: Hertzian (yellow) versus combined cantilever-Hertzian models (blue) for  ( ) . 
Percentages represent the decrease in Σ(  ) by going from Hertz to combined cantilever-Hertz 
model. p-values were calculated by the Wald F-test. 










This provided a rudimentary model for effective Young’s modulus and allowed for a secondary 
calculation of      for meshes.   in this case was taken to be 10 nN due to its proximity to the 
weight of a cell given   ≈ 10
 
  
. Results using this mode of calculation more closely reflected 
expected values, with low [PDMS], high [PDMS], and PCL meshes yielding      values of 294 + 61 
kPa, 251 + 81 kPa, and 1.58 +  0.21 MPa, respectively (see figure 14, dark blue columns). Although 
these more closely matched expected values for      than with those in figure 11C, these figures 
were nonetheless slightly higher than expected, thus indicating that further modifications on 
Euler-Bernoulli theory may increase the accuracy of our model. 
Notably, as      is a function of  , it can be broken down into its cantilever (  =    + 0.5 ) and 
Hertzian (   =  √  + 0.5  ) constituents. Analysis of the resulting decomposition strongly 
indicated that cantilever forces dominate the equation, especially at lower rigidities. As seen in 
figure 14 (green columns), cantilever contributions composed approximately 82.2%, 86.4, and 
69.7% of the overall      value for low [PDMS], high [PDMS], and PCL meshes respectively. This 
effectively indicated that as cantilever forces dominated, cells are sensing more macroscopic 
rather than local, microscopic forces on the mesh.  
In order to expand upon this model and obtain a function of       in terms of geometric 
parameters   and  , we first reconstructed the equation for      to separate the Hertzian and 
cantilever components, while simultaneously applying Euler-Bernoulli theory to beam deflection. 
That is, given  ( ) as: 
 ( ) =
  (   −   )   ⁄
9√3   








Figure 14: (A)      as calculated by basic modification of Euler-Bernoulli theory via      ( ). Error 
bars represent mean + standard deviation, n = 5. (B)       and corresponding cantilever 
contributions. Standard deviations n = 5 with respect to     . 









Although     ( ) as written provides a reasonable estimate of effective Young’s modulus, it is still 
a function of x. Ideally, a model would provide an overall estimate for the average effective Young’s 
modulus for an entire mesh. To make this shift,  ( ) was approximated as  ̅ by determining the 
average distance between any one point on the mesh and a fiber node via SEM images and 
acquiring the value of  , the Young’s modulus of the bulk material. To this end, slabs of low [PDMS] 
were synthesized via direct casting onto glass coverslips and subjected to AFM analysis as 
described previously. Although values for E of the casted slab varied, rigidities were found to be 
approximately 2.11 + 0.84 MPa (n = 8 sample areas). The equation for deformation thus was 
reduced to a function of F, which, once placed back in the equation for     , became independent 
of pFS. Since the Hertzian contribution was negligible for softer meshes (less than 20%) a reduced, 
simplified version of      was obtained: 




Notably, the absolute value of the offset value c was found to be less than 25 kPa for low and high 
[PDMS], while values reached as high as 107 kPa for PCL meshes. Ideally, these values would be 
zero, thus indicating that our model was not a perfect predictor of     . However, the lack of      
dependence on   was particularly beneficial since given a set material composition and relatively 
small exerted forces by the cell, effective rigidity should not be dependent upon probing force 
While this model does provide a reasonable estimate, there are multiple factors that were not 
considered, including but not limited to tip adhesion, fiber-fiber traction forces, slippage, and peak 
force error. Future models may indeed analyze the contributions from these forces, however, for 
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the purposes of this study, these contributions were considered to be negligible compared to 
macroscopic beam bending deformations. 
Specific aim 2b: Verification of quantitative model for PDMS/PCL mesh rigidities 
Our aforementioned derived model allows us to estimate the effective Young’s modulus for a 
mesh as a function of r, and L, given a fixed bulk material Young’s modulus E. Notably, the majority 
of the value of      came from was from the cantilever force contribution: this indicated that it is 
the macroscopic beam bending motion that cells primarily responded to, not local microscopic 
forces driven by the rigidity of the material itself. Therefore, given an array of different meshes 
constant materials composition but L, one can effectively calculate       and perform the 
associated cell expansion as detailed in specific aim 1 of this report. For this segment, meshes with 
     in the 10 – 500 kPa range were targeted in order to provide suitable comparison to the planar 
surfaces synthesized by O’Connor et al.  
In order to validate our model, a series of meshes with differing values of average fiber radius r 
and average inter-node fiber length L were synthesized and the values for      calculated. The 
low [PDMS] formulation was chosen for this final experiment due to its lower spinning time and 
more stable spinning process than its high [PDMS] counterpart. The formulation used in specific 
aim 1 of this report was used to create fresh low [PDMS] meshes as a starting point (herein termed 
mesh A); from here, electrospinning parameters, such as working distance, accelerating voltage, 
and spin rate were modulated in order to produce mesh variants. The resulting original mesh 
formulation was observed to have fiber diameter 2.28 + 0.46 µm, while subsequent variations 
yielded fiber diameters of 1.82 + 0.33 µm, 1.27 + 0.28 µm, 0.55 + 0.10 µm, and 9.39 + 1.82 µm, 
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herein termed meshes B, C, D, and E, respectively (see figure 15). Resulting values for      ranged 
from 61.9 + 8.4 kPa and 29.7 + 3.5 kPa in meshes A and B, respectively, to upwards of 387.8 + 34.3 
kPa in mesh D. Although mesh E had the highest fiber diameter at almost 10 µm, its      is lower 
than that for mesh D primarily due to its larger fiber lengths. Mesh D on the other hand appeared 
stiffer despite having the smallest fiber diameter of this set due to its very short fiber length.  
 
 
Figure 15: (A) Fiber diameters and average inter-nodal fiber length for meshes A through E (left) 
and resulting      from model calculations (right). Values are mean + standard deviation with n = 






Meshes were subsequently mounted, coated with activating antibodies, and used as expansion 
substrates for naïve T cells derived from healthy donors as described in specific aim 1 in 
conjunction with Dynabead® controls. Expansion profiles once again reflected profiles observed 
with healthy donor cells as in specific aim 1, where cultures underwent an initial blasting phase 
for seven to nine days as tracked by cell volume before returning to rest. Importantly, the two 
softest meshes, A and B, (     ≈ 60 and 30 kPa, respectively) were observed to yield the highest 
number of maximum doublings at 6.63 + 0.34 and 6.67 + 1.27 doublings, respectively. In contrast, 
the stiffest mesh, D, (     ≈ 390 kPa) yielded 4.17 + 0.42 doublings (see figure 16). This may again 
be in part due to its dense fiber structure, however, its geometric parameters yielded a much 
higher rigidity than its softer mesh counterparts. In addition, PI and %div data for meshes A 
through E varied from 1.47 to 1.72 and from 44.2% to 68.1%, respectively; these values were not 
seen to deviate significantly from those acquired from the previously run healthy donor 
expansions (data not shown). Following completion of primary blasting phase, cells were again 
harvested, frozen down, and subjected to restimulation assays for IFNγ secretion in CD4+ cells and 
CD107b expression levels on CD8+ cells. Restimulation assays yielded the same pattern as previous 
expansions with healthy donors, in which secretion and expression levels were not found to vary 
significantly (α = 0.05, n = 3, ANOVA) across all mesh types, thus indicating that cells retained 





Figure 16: (A) Expansion profiles for meshes A through E. All mesh types n = 3 except for 
Dynabeads® (n = 1). (B) Restimulation experiment results for meshes A through E. All error bars 
represent mean + standard dev, α = 0.05). 
This section of the report served as a validation for our previously formulated model. Notably, 
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maximum doublings for the softest meshes, A and B, were comparable to those achieved by the 
1:5 planar PDMS formulation synthesized by O’Connor et al, in which surfaces of rigidities of 
approximately 50-110 kPa were found to yield approximately 6.6 maximum doublings from a 
starting population of 1 million T cells in the same culture conditions. Although other 
aforementioned factors may still play a role in determining the true value of      for microfibrous 
PDMS/PCL meshes, this analysis indicates that this model may be viable as a first approximation 
of     . 
In summary, specific aim 2 has seen the development of a quantitative model for the effective 
Young’s modulus       as a function of materials synthesis parameters  , the inter-nodal fiber 
length and  , the fiber radius, through a combined AFM and SEM-based study, as well as drawing 
upon the fundamental mechanics of beam bending as found in Euler-Bernoulli theory. Validation 
of this model via the expansion of human T cells as previously done in specific aim 1 and previous 
work by O’Connor et al indicate that this model provides a reasonable estimate of      for fibrous 
meshes with set bulk material properties.  
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Conclusions and Future Directions 
Summary and conclusions 
Our motivation in developing the mesh platform described in this report was twofold. The primary 
goal is to improve upon the potential safety concerns in the use of the Dynabead® platform by 
having a single continuous substrate for ease of removal and lack of activating antibody being 
transfused into the patient along with the cell product while still maintaining a high surface area 
to volume ratio. In addition, our secondary goal was to engineer this platform to effectively allow 
for the leveraging of T cell based mechanosensing, a phenomenon previously demonstrated by 
our lab through observed trends towards higher levels of cell proliferation and IL-2 secretion on 
softer substrates. 
Experiments conducted in this report have indicated that there is indeed a correlation between 
surface rigidity, cell activation, and cell proliferation in healthy patient-derived naïve human T cells. 
As evidenced by our experiments, cells are indeed penetrating into and becoming activated by the 
PDMS/PCL meshes. More importantly however is the trend, in which meshes made of the softest 
material achieved anywhere from two to approximately four more doublings from the same 
starting population as the clinical gold standard while maintaining comparable levels of cell 
activation, as measured by CD4+ cytokine secretion and cytotoxic CD8+ surface protein expression, 
and phenotypic distribution. Similar trends were also observed in cell volume progression, 
indicating comparable growth trends and blasting phases between cell populations. The first 
section of this report therefore indicated that the leveraging of T cell mechanosensing can indeed 
be achieved through the use of fibrous PDMS/PCL meshes with micron-scale geometries, thus 
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proving our original hypothesis correct. This is of particular importance in CLL patient cells, as the 
expansion of exhausted (PD-1high) cell populations remains an active challenge in the full 
realization and clinical adaptation of adoptive cell transfer. 
Central to the observations seen in this experiment was the ability to effectively tune fiber 
geometries in order to synthesize a platform with features that mimic the in vivo environment of 
the cortical and medullary thymus where T cells undergo final maturation. Our strategy in using 
PDMS, a non-toxic polymer approved by the FDA for use in medical devices, as the underlying 
material was largely due to its ease in rigidity modulation: by altering the base to crosslinker ratio, 
one is able to generate various substrates with different rigidities. In order to synthesize meshes 
via electrospinning, the addition of PCL was necessary in order to form a stable polymer feed with 
suitable viscosity. This effectively allowed for the synthesis of a series of meshes with microscale 
fibers and pores with diameters on the order of 1-2 µm and 9-12 µm, respectively as confirmed 
by SEM. This was of particular importance to us as it was hypothesized that these dimensions 
would promote cell migration into the mesh and fully leverage the high surface area to volume 
ratio of our construct. This was later confirmed via fluorescence microscopy: cellular actin staining 
coupled with mesh fiber staining revealed cells burrowing into the mesh and clinging onto fibers 
coated with agonists to CD3. While the precise mechanism and traction forces for T cell adhesion 
are still subjects of active research, images obtained in our preliminary studies have indicated that 
cells mostly tend to hug fibers, although some cells that adhere at fiber junctions will straddle 
different fibers. This will inevitably induce changes and additional stresses to the cytoskeleton, as 
there was a driving force towards stretching the cell membrane further in order to maximize cell-
fiber contact. This intersection of T cell biology and biomechanics presents itself as a future 
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potential avenue of study, as full elucidation of this behavior and the underlying proteins involved 
may lead to new techniques for the advancement of T cell-based immunotherapy.  
Functionalization of meshes with activating antibodies to CD3 and CD28 provided for the primary 
and secondary T cell activation signals, respectively, and allowed for subsequent cell proliferation 
and stimulation. This binding process was performed via direct adsorption in this preliminary 
model. As evidenced in our study, this led to antibody desorption across the three days of cell 
stimulation, although the protein desorption did not appear to induce overstimulation of cells in 
culture in subsequent days. To mitigate this however, a covalent linkage strategy, for example via 
the biotin-streptavidin route, will be a potential focus of future experiments as discussed in the 
future directions section. 
In addition to the aforementioned safety concerns, the primary observed advantage in our mesh 
platform has been its ability to induce higher levels of cell proliferation while maintaining similar 
levels of cell activation and functionality. As evidenced by our expansion data, PDMS/PCL meshes 
demonstrated the ability to outperform the Dynabead® platform by upwards of 5.6 to 12.5 times 
more cells in healthy patients. This fact, coupled with the comparable levels of IFNγ secretion in 
CD4+ cells, CD107b membrane expression on CD8+ cells, and overall phenotype distribution, is of 
particular importance, as this implies that the production of large amounts of active cells from an 
even smaller starting number is possible with the mesh. This is critical for the success of ex vivo 
expansion, as this would ideally allow technicians to withdraw less blood from the patient in order 
to produce the same results, particularly in the case of patients with weakened immune systems. 
Such is the case with patients suffering from various chronic illnesses such as CLL, where the 
expansion of exhausted PD-1high T cell populations has previously posed a challenge to the 
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Dynabead® platform. As our current experiments show that PDMS/PCL meshes can produce up to 
8.5 to 18.3 times more cells in CLL patients than Dynabeads® while again retaining similar levels 
of activation, we strongly believe that our mesh holds significant promise for improving the 
landscape and clinical development of adoptive immunotherapy.  
In order to more fully elucidate what rigidities the cell sees on the mesh, a second set of 
experiments was designed to focus on mesh rigidity measurements via AFM. Our fluorescence 
imaging data in this experiment indicated that upon interaction with the mesh, cells will either hug 
a single fiber or adhere to several fibers at a node. Cells in these configurations will thus apply 
forces both normal to the mesh and tangential to the mesh (traction forces). Although preliminary 
experiments on the former, involving seeding T cells onto micropillar arrays, have indicated that 
traction forces are on the order of 0.1 nN, this phenomenon remains not fully studied.  
We therefore aimed to build off the work of Baker et al by probing the effects of different forces 
on microscale perceived rigidities and bending stiffness. While their work focused on PCL fibers 
via tangentially applied forces in AFM, ours focused on the use of PDMS/PCL hybrid fibers and 
probing forces normal to the fiber. Besides spanning a different range of rigidities, testing of 
PDMS/PCL fibers posed an additional challenge as our blended fibers have been observed to be 
more adhesive than PCL fibers. In other words, additional forces and phenomena stemming from 
intrinsic material properties as well as mesh geometry were necessary to be taken into account 
for this experiment. This was perpetuated by our initial findings via AFM that local rigidity values 
for experimental meshes ranged from approximately 640 kPa to 1.4 MPa, with additional increases 
in rigidity associated with aging of fibers. Given the relatively high cell expansion numbers achieved 
by experimental meshes, there was thus a discrepancy between these initial AFM-reported rigidity 
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values and our expected findings, namely, that rigidities would range in the tens to low hundreds 
of kPa. Our goal here was thus to construct a more accurate quantitative model for the perceived 
rigidity, termed     , as experienced by the cell. Considerations in calculating bulk rigidities thus 
needed to be modified in order to construct such a model. 
Analysis of mesh-adherent cells were conducted along the baselines of simple mechanics, starting 
with the fundamental theory of Euler and Bernoulli. For this analysis, we approximated the mesh 
fiber as a uniform cylindrical beam with fixed radius, calculated from SEM and AFM images. Due 
to force-dependent deformations in preliminary AFM scans, deformation   was postulated to be 
comprised of both Hertzian and cantilever mechanics contributions, as opposed to purely Hertzian 
as with standard AFM models for rigidity calculation. That is, in lieu of a direct proportionality 
between   and the square root of applied force, we postulated that deformation would be a sum 
of a linear and root component of applied force, in addition to a linear offset factor to account for 
experimental error. 
Applied force was approximated as the peak force setpoint, or pFS, exerted by the AFM tip. In 
actuality, the total force experienced was not simply the pFS, but would include contributions from 
other factors such as materials adhesive forces, traction forces from fiber-fiber interactions, the 
weight of the cell pushing down on the fiber, etc. However, these factors were not taken into 
consideration in this model due to their negligible contributions. For example, previous reports by 
Phillips et al have indicated that an approximate mass for a T cell at rest (V = 230.9 ± 78.5 fL) as 
18.7 ± 0.6 pg39. As the cell is in an aqueous environment during stimulation, factoring in the 
buoyancy force amounts to a very negligible additional force on the order of < 1 pN.  
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Approximation of average deformation  ̅ through analysis of the average distance from any node 
a point on a fiber resides via SEM scans, combined with material-specific curve fitting and the 
overall dominance of cantilever force contributions to the overall value of       allowed us to 
formulate an equation for      that was independent of force and only depended on mesh fiber 
geometries. This was of particular importance as it demonstrated that within forces in the nN 
range and similarly to the bulk material Young’s modulus,      is independent of applied force. 
Note that   ≠      , as the former refers to an intrinsic material property driven by the 
intermolecular forces of attraction of chemical structure of the material, while the latter is 
dependent upon the actual geometry of the material. Through this process, the values of      for 
low [PDMS] and high [PDMS] meshes were estimated to be 294 and 251 kPa, respectively. While 
this much more closely matched expected values, it should be noted that the rigidities of these 
fibers did not differ significantly from each other. This would support the previous observation in 
specific aim 1b in the cell proliferation experiments: although both experimental meshes yielded 
significantly more doublings than with the Dynabeads® platform, the difference in maximum 
doublings between both meshes was not significant. If the cells were responding to perceived 
substrate rigidity, as was postulated, this similarity in rigidity would have manifested in a similar 
cellular response. The correlation between the significantly higher      value for pure PCL meshes 
and the decreased number of doublings elicited further supports this conclusion: pure PCL meshes, 
which were estimated to have perceived rigidities of approximately 1.58 MPa, or about 5-6 times 
more rigid than PDMS/PCL meshes, yielded only 6 maximal doublings, compared to 9-10 maximal 
doublings for experimental meshes. This production of upwards of 8 to 16 times more cells on 
experimental meshes over rigid control meshes indicates that mechanosensing was indeed at play. 
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Note that protein adhesion was seen to desorb from experimental and control meshes at a similar 
rate during the cell activation phase of the experiment, thus indicating that differences in cellular 
response is driven by the material and material geometry, not by the antibody coating. 
As cells predominantly felt cantilever forces on the mesh, an array of mesh fibers made of the 
same material were synthesized in order to attain values of      on the range of 10
4 to 106 Pa as 
calculated by our constructed model. Correlation of the resulting expansion profiles with the study 
performed in 2012 by O’Connor et al revealed that mesh performance was on par with those on 
a planar surface in order of comparable rigidity. By comparing the cell proliferation and activation 
of a planar surface and a mesh surface of equal rigidity (or pseudo-rigidity), one can directly 
evaluate the effect of using a mesh as a culture substrate instead of a planar surface. Such 
information would hold significant promise in advancing the development of T cell-based adoptive 




Future directions  
Although the results from this series of experiments hold significant promise for furthering the 
advancement of ACT, this work also opens up multiple areas for future research from both a basic 
science as well as a materials and biomedical device engineering perspective. 
One key evaluation criterion in the adaptation of an ex vivo stimulation platform for clinical use is 
its ability to produce sufficient numbers of cells, as well as compatibility with existing production 
mechanisms. Bench-scale expansion protocols, as presented in this thesis, have yielded promising 
results. However, larger-scale processes will have to be developed in order to fully realize this 
technology in the clinical setting. The Dynabead® platform is readily scalable: one easily can 
modulate the amount of beads added to a bioreactor system to accommodate higher starting 
populations. However, our PDMS/PCL mesh platform is less dense than water and thus floats 
without another substrate to weigh it down. Coating the inner surface of a bioreactor is one 
possibility, however, this is likely not feasible given the current electrospinning technology. One 
potential idea explored by our lab thus far is the use of PDMS/PCL meshes on printed three-
dimensional polymeric scaffold inserts that can be mounted inside standard 50 mL centrifuge 
tubes. Preliminary models conducted by culturing cells on these mesh scaffolds have consisted of 
mounting centrifuge tubes onto a rotating platform, thus providing cells with slow, constant 
mixing, with manual oxygenation by opening up tubes every 12 h in a sterile incubator 
environment. Although cell populations cultured through this process have been observed to have 
comparable levels of activation to small-scale expansions, this process involves many manual steps 
and would not be viable for commercial processes. Therefore, there is a need for the development 
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of cell engineering devices and protocols to better incorporate the PDMS/PCL mesh platform into 
a more well-automated, scalable, bioreactor.  
Current manifestations of the mesh platform have activating antibodies linked to the underlying 
mesh via direct adsorption. We have demonstrated that the dissociation of antibody from the 
mesh is relatively low, at approximately 70% antibody attachment upon separation of cells from 
the activating surface. However, this dissociation of antibody may lead to adverse patient reaction 
if left in the final cell transfusion, especially given the fact that the antibodies in question are 
general agonists for both the primary and secondary stimulation signals for naïve T cells. Therefore, 
there exists a need to further develop a method to covalently link activating antibody to the 
surface of the mesh. One possible and viable option is the use of a biotin / streptavidin linker and 
directly tether anti-CD3 and anti-CD28 molecules to the mesh without the intermediate use of the 
capture antibody as was done in this series of experiments. This would effectively decrease the 
cost of platform manufacturing as well as increase patient safety. 
Other design parameters can be optimized as well: for example, although our platform was 
observed to significantly yield higher levels of cell division than the clinical gold standard, the use 
of mechanical pipetting utilized to harvest cells may have left cells stuck in the mesh matrix. It 
should be noted that while cells are seen to naturally detach from the mesh typically around day 
4, cells were harvested at day 3 in order to keep protocols in line with the Dynabead® expansion 
protocol. Therefore, in order to increase the harvesting efficiency of stimulated T cells from the 
mesh, one could construct a degradable mesh, in which the addition of a compound would cause 
the fiber matrix to break down. Subsequent centrifugation and washing with media or buffer 
would allow for the separation of cells from broken down mesh fibers. This would be analogous 
 
91 
to the use of citrate, a chelating agent for calcium ions to break down alginate, a naturally 
occurring polysaccharide whose characteristic egg-box structure is stabilized by calcium ions. The 
use of alginate may not be of optimal usage in the context of T cell immunotherapy due to the 
concentrations of calcium released by the degradation of the alginate structure and the potential 
fragility of patient cell populations. However, other materials with similar degradation properties 
and low rigidities may have use in the context of the engineering of the mesh platform. 
An additional design parameter of note is the inclusion of PCL in the electrospinning feed. As 
previously discussed, PCL was utilized in the electrospinning of our PDMS-based meshes in order 
to serve as a viscosity modulator. Notably, PCL is biocompatible, non-cytotoxic, and readily 
commercially available. Ideally however, this mesh platform would be synthesized out of pure 
PDMS, or PDMS and a softer, biocompatible material, in order to achieve lower rigidities. One 
potential workaround is the use of a hydrogel system instead of an electrospun mesh system, but 
with pore sizes similar to ones on PDMS/PCL meshes from this series of experiments. This could 
potentially allow for even higher levels of cell activation and proliferation through the presentation 
of softer surfaces while retaining the high surface area to volume ratio and other desirable 
properties of the mesh. 
Furthermore, studies performed thus far have focused on the activation and proliferation of 
conventional, CD4+ and CD8+ T cells. While the expansion of these cell types will undoubtedly be 
useful for the treatment of a wide range of chronic illnesses in which the patient’s immune system 
is unable to successfully restore homeostasis, these cell types will not be as effective for the 
treatment of autoimmune diseases. In these diseases, such as type II diabetes, inflammatory 
bowel disease (IBD) and rheumatoid arthritis, the promotion of regulatory T cells may prove useful 
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in suppressing an overactive immune system. As regulatory T cells are notably different than 
conventional CD4+ and CD8+ T cells in surface marker expression and behavior, further research 
may prove useful in optimizing mesh design parameters for these applications. 
While the expansion of CLL patient-derived T cells showed strong indication that our softer 
substrates can invoke higher levels of cell activation and proliferation than the clinical gold 
standard, the high degree of patient to patient to variability, even in the same Rai stage, alludes 
to other variables than Rai stage at play in terms of indicating whether or not a patient’s cells were 
suitable for expansion. This is not of particular surprise, as the Rai stage of a patient only refers to 
the enlargement of the spleen, lymph nodes, or lack of certain cell types, not particular 
characteristics of the mutated B cells themselves. One possible hypothesis for this variance lies in 
the genetic mutation rate of the variable region of the B cell receptor (BCR) heavy chain (VH). 
Intriguingly, studies conducted by Stilgenbauer et al. have suggested that higher levels of VH 
homologies at mutations sites on chromosomes 11, 12, and 17 correlate to a decrease in patient 
survivability27. As demonstrated in figures 2 and 3 of their paper, the estimated average 
survivability for patients with VH homologies > 97% in these regions is approximately 79 months’ 
post diagnosis, compared to over 192 months for patients with higher levels of genetic mutation. 
Although the exact mechanism for this has not been fully explored yet, this phenomenon may 
have implications for determining which CLL patients’ cells would be suitable for adoptive 
immunotherapeutic expansions. Additionally, work by Damle et al has indicated that the 
expression of surface marker CD38 may be another potential indicator for cell survivability, and 
perhaps ease of cellular expansion38. In their analysis, Damle et al showed that patients with a 
higher expression rate of CD38+ mutated B cells (defined as 30% or more) had a higher percentage 
 
93 
of B cells with mutated VH homologies. As such, future experiments may focus on the expansion 
of cells from patients with different VH homologies and/or expression levels of CD38 of over 30%, 
but with the same Rai stage. 
AFM studies conducted in this series of experiments have been done with the overall goal of 
elucidating what rigidities a T cell experiences upon coming in contact with the mesh. However, 
the microscale geometries characteristic of the mesh and indentation forces from the AFM tip do 
not lend themselves well to any commonly used models for AFM-based rigidity calculation. The 
reasons behind this are clear: besides the fact that microscale fibers do not resemble semi-infinite 
planes, observations thus far have indicated that the observed rigidity of the mesh appears to be 
a quadratic function in the maximal applied force, or pFS. Additionally, substrate deformation also 
appears to vary with pFS; this is in direct deviation with the standard AFM models for rigidity, 
specifically the Sneddon and DMT rigidity models, as substrate deformation is assumed to be zero 
or negligible in both cases. Ideally, the pFS would be equal to the force exerted by a T cell on the 
mesh; however, this information has yet to be fully studied. 
Additionally, our quantitative model has notably omitted the contributions from a wide range of 
other factors that may affect      such as fiber-fiber traction forces, tip adhesion forces, and peak 
force error. Although these forces were not considered significant for the purposes of this model 
due to their hypothesized low contribution to the      as a whole, a more in-depth model can be 
constructed to account for these factors. This would likely involve a re-derivation of Euler-Bernoulli 
theory and the calculation of deformation with respect to characteristic fiber length scale. Also 
due to the dual material composition of our PDMS/PCL meshes, tip adhesion forces need to be 
considered carefully as while PDMS is a relatively adhesive material, PCL is much less so. The notion 
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of persistence length was also omitted from this experiment due to the short length scales 
associated with inter-nodal fiber distances. However, for meshes composed of longer fibers, such 
as mesh formulation E from the model verification experiments, the notion of persistence length 
may come into play. 
Furthermore, many of the fundamental assumptions from Euler-Bernoulli theory were held 
constant throughout the derivation of this model, such as a uniform cross-sectional area and 
uniform shear modulus, may in fact not hold true with these meshes. As observed in SEM 
micrographs and AFM topological scans, fibers are not perfect circular cylinders, but may be best 
modeled as cylinders with elliptical cross sections: fibers tend to be flattened slightly parallel to 
the plane of the collection electrode and are stacked on top of underlying mesh fibers. Likewise, 
shear moduli of meshes, which was not considered for the purposes of this model, may come into 
consideration due to how the cell interacts with the mesh. Focal adhesions between a T cell and a 
mesh fiber will result in not just a force normal to the direction of the fiber, but a pulling force 
tangential to this direction as well. Such a pulling force will contribute to fiber deformation, and 
will thus require consideration of the shear modulus of the fiber. However, the strength of such 
forces has not yet been fully studied as of this writing. 
One final point of discussion about the utility of our derived model is that verification of this model 
has only been tested with our PDMS/PCL mesh system. As research towards development of an 
improved platform for T cell-based ACT continues to evolve, new materials and fabrication 
techniques may be developed. As a result, this model may not be fully accurate for other mesh 
systems: testing with other materials and mesh compositions may be necessary to further develop 
this model to yield a more unifying equation for      in fibrous meshes. 
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As the average lifespan increases and the prevalence of chronic illnesses, including but not limited 
to cancer, increases in turn, the demand for immunotherapeutic technologies will rise as well. As 
the results from this series of experiments open up a multitude of new avenues of research, it is 
with great likelihood that further development of realization of ACT will be perpetuated by the 
continuation of this research. Be it in the modification of design parameters to improve mesh 
performance, the engineering of improved methods for scalability and clinical adaptation, or the 
development of a more rigorous model for     , the avenues of research opened up by this series 
of experiments will be invaluable to the development of adoptive immunotherapy and 
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